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ANATOMY OF TETRALOGY OF FALLOT 
Tetralogy of Fallot (TOF) is characterized by  four anatomical lesions: pulmonary and/or 
sub-pulmonary stenosis, ventricular septal defect (VSD), overriding of the aortic orifice 
and concentric right ventricular (RV) hypertrophy as a secondary feature.1, 2 In 1888 Arthur 
Fallot published his well-known paper describing the combination of these four anatomical 
features in “la maladie blue”.3 From a pathophysiological point of view, the dominant 
feature of TOF is the anterior deviation of the outlet septum.1, 2, 4 This deviation results in 
a sub-pulmonary stenosis, sub-aortic VSD and dextraposition of the aorta overriding 
the ventricular septum.1, 2 These features cause RV pressure and volume overload resulting 
in concentric RV hypertrophy. The outlet septum is part of the supraventricular crest, and in 
normal hearts forms a continuum with the ventriculo-infundibular fold and the trabeculo 
septomarginalis (Figure 1a, normal RV). In TOF as compared to the normal heart, the outlet 
septum is recognizable as a separate structure, due  to the above mentioned anterior 
deviation (Figure 1b, tetralogy of Fallot). The morphology of the outlet septum in TOF 
varies considerably. The thickness of the outlet septum varies from severe hypertrophied 
myocardium to fibrous tissue.1, 2 TOF is also associated with other lesions, for example atrial 
septal defect (also known as Pentalogy of Fallot), atrioventricular septal defect (associated 
with Down syndrome), anomalies of coronary arteries (especially a so-called conal branch 
crossing over the right ventricular outflow tract (RVOT)), and stenosis of the pulmonary 
trunk and pulmonary arteries, possibly related to lack of flow through the narrowed outflow 
tract during development.1
REPAIR OF TETRALOGY OF FALLOT 
After introduction of the cardiopulmonary bypass by Gibbon in 1953, Lillehei was in 1954 
the first to perform intracardiac repair of TOF at the University of Minesota.5-7 During TOF 
Figure 1. Overview of the right ventricle of a normal hart (panel A) and a tetralogy of Fallot heart (panel 
B), please note that the outlet septum (*) is recognizable as a separate structure in tetralogy of Fallot. *, 
outlet septum; MB, moderator band (i.e. trabeculo septomarginalis); TV, tricuspid valve; VIF, ventriculo-





repair, the sub-aortic VSD is closed with a patch. To prevent damage to the His-bundle, care 
is taken to stich some millimetres away from the edge of the post-inferior rim of the VSD, 
which is most often perimembranous, but can also be muscular.8, 9 The infundibular right 
ventricular outflow tract obstruction is relieved by resection of infundibular muscle,  valvular 
RVOT obstruction is relieved by commissurotomy of the pulmonary valve and/or incision 
of the pulmonary annulus with  augmentation by using a transannular patch.8 Initially, 
repair of TOF was performed via a large RV incision and frequently with the use of a large 
transannular patch. The RV incision and transannular patch, which may result in significant 
pulmonary insufficiency, are associated with chronic RV volume overload, RV dilation, RV 
dysfunction and arrhythmias.8, 10 Therefore, a transatrial-transpulmonary approach has been 
introduced and RV incision is largely omitted. In case of a narrow pulmonary annulus, a small 
transannular RVOT patch is still required during transatrial-transpulmonary repair. Presently, 
most TOF patients undergo transatrial-transpulmonary repair in the first year of life.8, 11 
EPIDEMIOLOGY OF TETRALOGY OF FALLOT 
TOF is the most common cyanotic congenital heart disease, both the incidence and 
prevalence in children is currently 0.4 per 1000 live-births/children. The prevalence of 
adults with TOF has doubled from 0.1 to 0.2 per 1000 adults between 1980 and 2010 and is 
expected to increase further.12-14 This increased prevalence in adults is due to the favourable 
surgical outcome. Nevertheless, the risk for sudden death in TOF patients (5 per 1000 patient 
years) is still 29-fold higher compared with an age-matched population.15, 16 Of importance, 
two-thirds of TOF patients who die suddenly or experience ventricular tachycardia (VT) are 
young to middle-aged adults with a preserved cardiac function.16-18 
VENTRICULAR ARRHYTHMIAS IN TETRALOGY OF FALLOT 
The burden of ventricular arrhythmias in adults with TOF is considerable with a prevalence 
of 14.6% (14.2% VT and 0.5% ventricular fibrillation(VF)), observed in cohort of 556 
adult TOF patients with mean age of 37±12 years.19 Ventricular arrhythmias encompass 
monomorphic VT, polymorphic VT and VF. ICD interrogation in TOF patients who have 
received an ICD for either primary of secondary prevention demonstrated that 82% of 
the ventricular arrhythmias that required ICD therapy were monomorphic, fast VT with an 
average of 213 beats per minute (bpm).20 These fast monomorphic VT can even be fatal in 
TOF patients with a preserved cardiac function. Two previous studies in TOF patients who 
were referred for radiofrequency catheter ablation (RFCA) of symptomatic spontaneous 
VT demonstrated that 24 of 26 (92%) spontaneous and induced VT were macro-re-entrant 
VT. The critical re-entry sites of these macro-re-entrant VTs were located within anatomical 
isthmuses.21, 22 The anatomical isthmuses in TOF are the result of the malformation itself or of 
the surgical repair and are bordered by valve annuli, RV-incision scar and/or patch material. 
Four potential anatomical isthmuses have been described, see Figure 2.22 A post-mortem 
morphological study about isthmus presence and dimensions in repaired TOF demonstrated 
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that all 27 TOF patients had at least one anatomical isthmus.23 This post-mortem study did 
not relate anatomical isthmus presence and dimensions to the timing and mode of repair 
which is relevant for present and future repaired TOF patients and therefore needs further 
study. It has been demonstrated that in TOF, the infundibular myocardiu showed cellular 
hypertrophy, endocardial thickening and interstitial fibrosis at the time of repair, which 
extent was positively associated with the time of repair.24 The pre-existing degenerative 
changes of the infundibular myocardium, cyanosis and pressure overload before repair and 
volume overload after repair might result in slow conduction which is critical for re-entry 
VT. The combination of  anatomical isthmuses and histopathological changes may explain 
that anatomical isthmus related VT is the dominant mechanism for ventricular arrhythmias 
in TOF. 
RISK STRATIFICATION FOR VT IN TETRALOGY OF FALLOT
Many retrospective observational studies have reported risk factors for VT in TOF. These 
risk factors include: the presence of a transannular patch, late repair (≥5 years of age), 
syncope, increase in QRS duration especially ≥180ms, non-sustained VT on Holter, moderate 
to severe pulmonary regurgitation, at least moderate dysfunction of the left ventricle or 
right ventricle, left ventricular longitudinal dysfunction and extensive ventricular fibrosis on 
cardiac MRI.10, 16, 26-32 One of the first, most well-known and frequently used non-invasive 
risk factor in TOF is QRS duration. QRS duration is positively associated with ventricular 
arrhythmias and sudden death.28, 29 QRS duration prolongation in TOF can for example be 
due to right bundle branch block (RBBB) as result of the surgical repair or be due to increase 
Figure 2. Overview of the four potential anatomical isthmuses in Tetralogy of Fallot. The 1st  anatomical 
isthmus is located between the tricuspid annulus (TA) and RV-incision/RVOT-patch, the 2nd anatomical 
isthmus between the RV-incision (or patch) and pulmonary valve (PV), the 3th anatomical isthmus 
between the PV and VSD-patch and the 4th anatomical isthmus between the VSD-patch and tricuspid 




in RV size/dilation.28, 33 However, the exact contribution of the VT substrate to QRS duration 
is yet unclear. The reported risk factors are used to select TOF patients to receive an ICD for 
primary prevention. However, in TOF patients who received an ICD for primary prevention, 
the percentages of appropriate therapy (8% per year) and disabling inappropriate ICD 
shocks (6% per year) demonstrate that risk stratification for the individual TOF patient is 
far from perfect and needs to be improved.20, 34 Larger studies with sufficient follow-up and 
validated risk stratification are unlikely to become available in the near future.35 Therefore, 
further study of the VT substrate as related to outcome in TOF is desirable. 
INVASIVE TREATMENT OF VT IN TETRALOGY OF FALLOT
The data available on RFCA of VT in TOF is limited, an overview of case series and cohort 
studies is provided in table 1.21, 22, 36-40 In TOF, VTs are fast (mean of 213 bpm) and subsequently 
often hemodynamically poorly tolerated limiting the time available for activation mapping 
during VT.20 To avoid this problem, most of the earlier studies included only TOF patients 
with relatively slow VTs (mean of 172 bpm).37-39 To overcome the limited time available for 
activation mapping of fast VT in TOF, the two most recent cohort studies used substrate 
mapping to target fast VT (mean of 222 bpm) requiring very little time of activation mapping 
or even rendering activation mapping unnecessary.21, 22 
 Substrate based ablation can be performed with contact mapping as demonstrated by 
Zeppenfeld et al.22 First VT is induced (three basis cycle length with up to three extra stimuli 
from at least two sites; RV apex and RVOT) to obtain QRS morphology. Second, during sinus 
rhythm, a 3D electroanatomical bipolar voltage map of the RV is constructed to identify 
the boundaries of the anatomical isthmuses (i.e. surgical scars, patch material and valve 
annuli; figure 2). Bipolar voltages of >1.5mV are considered normal. In areas with bipolar 
voltage <1.5mV, high output pacing (up to 10mA, 2 ms) is performed. If high outpacing 
does not capture, these areas are tagged as electrically unexcitable scar (EUS) consistent 
with surgical scars and patch material. After identification of the anatomical isthmuses, 
the critical re-entry circuit isthmus of the induced VT can be identified by activation 
mapping (diastolic activity during VT and slowing or termination during radiofrequency (RF) 
ablation), by entrainment during VT or by pace-mapping (pace-match, ≥10/12 leads) if VT 
cannot be hemodynamically tolerated. If the critical re-entry circuit isthmus site is located 
within an anatomically defined isthmus, the anatomical isthmus is transected with a linear 
radiofrequency lesion until  bidirectional block can be demonstrated. 
Substrate based ablation can also be performed via non-contact mapping as 
demonstrated by Kriebel et al.21 First, a catheter is used to construct a RV map. Thereafter, 
a multi-electrode balloon that simultaneously records virtual unipolar electrograms is used. 
On the RV map, low voltage areas are identified that can serve as areas of conduction block 
during macro re-entrant VT (i.e. boundaries of the anatomical isthmuses). Thereafter, VT is 
induced and VT propagation is traced throughout the whole RV theoretically during one 
heart beat beats permitting fast mapping of hemodynamically unstable VTs. In the majority 
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Table 1. Overview of currently available case series and cohort studies of radiofrequency catheter ablation 













Burton36, ’93 TOF (2) 2 PM 270±28 2/2 0/2 4±3
Horton39, ‘97 TOF (2) 2 AM + LL 430±71 2/2 0/2 11±0
Cohort
Gonska38, ‘96 TOF (7), PS (2),  VSD (1),  
VSD+TGA (1)
11 AM 377±74 9/11 2/11 20±9
Morwood40, ‘04 TOF (8), VSD (3), other (3) 14* x x 10/20 4/10‡ x
Furushima37, ‘05 TOF (4),  DORV (3) 7 AM + LL 346±77 4/7 6/7 61±29
Kriebel21, ‘07 TOF (10) 10 SM + LL 270±40 8/10 2/8‡ 35
Zeppenfeld22, ‘07 TOF (9),  AVSD (1), 
VSD+TGA (1)
11 SM + LL + 
IMG
276±78 11/11 1/11 30±29
*, 14 patients with 20 procedures; ‡, patients with acute success; AM, activation mapping; AVSD, atrioventricular 
septal defect; CHD, congenital heart disease; DORV, double outlet right ventricle; IMG, image integration using 
CT; LL,  linear lesion; PM, pace-mapping; PS, pulmonary stenosis; Pts, patients; SM, substrate mapping; TGA, 
transposition of the great arteries; TOF, Tetralogy of Fallot; VSD, ventricular septal defect.
of patients (80%), the VT was macro-re-entrant. As stated above, if the anatomical location of 
the VT critical isthmus site is identified within an anatomical isthmus, the anatomical isthmus 
is transected with a linear RF lesion and checked for bidirectional block. So far, the published 
studies concerning RFCA of VT in TOF are small with limited follow-up, especially the studies 
targeting fast VT. Therefore, larger studies with longer follow-up are desirable. 
AIM AND OUTLINE OF THESIS
The aim of this thesis is to improve the understanding of the VT substrate in TOF, 
and subsequently improve VT risk stratification and invasive treatment of VT. In 
chapter two, in a cohort of 74 TOF patients who are considered at risk for VT, the properties 
of the anatomical isthmuses (i.e. width, length and conduction velocity) are determined by 
electroanatomical mapping during sinus rhythm. The properties of the anatomical isthmuses 
related to VT are compared to anatomical isthmuses of patients without VT in order to 
identify isthmus characteristics that can be used for individualized risk stratification and 
preventive ablation. Chapter three describes the acute and long-term outcome of RFCA of 
anatomical isthmus related VT in a large group of 32 patients with repaired congenital heart 
disease, predominantly TOF. RFCA in this group was performed using substrate mapping and 
bidirectional block of the anatomical isthmus that contains the critical VT re-entry circuit site 
as a procedural endpoint. In TOF, anatomical isthmus related VT of the septal anatomical 
isthmuses cannot always be successfully ablated via a right-sided approach, and sometimes 




anatomical considerations when performing a left-sided approach are discussed in chapter 
four. Chapter five describes the contribution of the VT substrate to QRS duration according 
to absence/presence of right bundle branch block in a cohort of 78 TOF patients. The final 
chapter (chapter 6) reports the influence of the repair itself, mode of repair and timing of 
repair on isthmus presence and dimensions in a cohort of 142 TOF post-mortem specimens. 
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The majority of ventricular tachycardias (VTs) in repaired Tetralogy of Fallot (rTOF) are 
related to anatomically defined isthmuses. We aimed to identify specific electroanatomical 
characteristics of anatomical isthmuses (AI) related to VT which may allow for individualized 
risk stratification and tailored ablation.
Methods and results
Seventy-four consecutive rTOF patients (40±16 years, 63% male) underwent VT induction 
and RV electroanatomical voltage and activation mapping during sinus rhythm to identify 
the presence and characteristics of AI (isthmus width, length and conduction velocity index 
[CVi]). Twenty-eight patients were inducible for 41 VTs. All 74 patients had at least one AI. 
However, AI in patients with VT were longer (22±7 versus 16±7mm, p=0.001), narrower (20±8 
versus 28±11mm, p<0.001) and had lower CVi (0.36±0.34 versus 0.78±0.24 m/s, p<0.001). 
Thirty-seven VTs in 24 patients were mapped (pace-, entrainment mapping and/or VT 
termination by ablation) to 28 AI. All 28 AI related to VT had a CVi<0.5m/s (slow conducting AI 
(SCAI)). In contrast, 87/89 AI of the 46 patients without VT had CVi≥0.5m/s. Sixty-two patients 
were discharged without the presence of a SCAI (44 had no SCAI at baseline, 18 underwent 
ablation of the SCAI) and 10 still had a SCAI (no/failed ablation). During follow-up (50±22 
months), no patient without SCAI had any VT, which occurred in 5/10 patients with 
SCAI (p<0.001).
Conclusion
In rTOF, slow conducting anatomical isthmuses identified by electroanatomical mapping 
during sinus rhythm are the dominant substrate for VT  allowing individualized risk 
stratification and preventive ablation.




Tetralogy of Fallot (TOF) is the most common cyanotic congenital heart disease across all 
age groups.1 The prevalence among adults is increasing as a result of earlier and improved 
surgical interventions.1, 2 Despite early repair patients have a 29-fold higher risk for sudden 
death compared to the age matched population.3, 4 Of concern, two thirds of patients who 
die suddenly or experience life-threatening ventricular tachycardia (VT), typically early to 
middle-aged adults, have preserved cardiac function before the first event.4-6 
Retrospective, observational studies have identified factors associated with VT, however 
these have limited predictive value.7 Earlier repair and progress in surgical techniques 
from a transventricular to a transatrial-transpulmonary approach may influence the VT 
substrate and its prediction. Large studies with long follow-up, required for validated risk 
stratification in patients repaired in the modern surgical era, will not be available in the near 
future.8 Direct identification of the substrate for VT in an individual patient could overcome 
the problem of lacking clinical arrhythmia predictors and would allow personalized risk 
stratification.9 Mapping studies performed in repaired TOF (rTOF) patients have identified 
re-entry as the dominant underlying VT mechanism.10-12 Re-entry circuits are typically 
related to anatomically defined isthmuses bordered by unexcitable structures such as 
surgical scars, valve annuli and patches.10-12 Anatomical isthmuses are however present in 
almost all rTOF patients but not all are related to VT. We hypothesized that specific isthmus 
characteristics are required to constitute the substrate for re-entry VT. The overall aim for 
the study was to identify these arrhythmogenic isthmuses by electroanatomical mapping 
allowing individualized risk stratification and tailored treatment.
METHODS
Patient selection and study design
The study cohort consisted of consecutive rTOF patients, who were considered at risk for VT 
or had documented VT referred for electrophysiological evaluation and treatment between 
2005 and 2013 (Leiden University Medical Center, Leiden, The Netherlands (n=52); Bordeaux 
University Hospital, Bordeaux, France (n=22)). Patients were considered at risk when at least 
one prior reported risk factor was present: syncope, QRS duration ≥180ms, non-sustained VT 
on Holter, at least moderate dysfunction of the left ventricle (LV) or right ventricle (RV), late 
repair (≥5years of age) and presence of a transannular patch (TA-patch).13-19 All patients were 
treated according to our standard clinical protocol (supplement A) and provided informed 
consent. Electrophysiological studies were only performed in rTOF patients considered at 
risk for VT, which is part of the clinical protocol, therefore no ethical commission approval 
was required. 
Medical records were reviewed for date and type of repair/re-operation and documented 
ventricular arrhythmias on 12-lead ECGs, Holter recordings or ICD interrogation. Non-paced 




echocardiographic and cardiac magnetic resonance (CMR) imaging studies were reviewed 
for assessment of biventricular function. 
Electrophysiological evaluation consisted of programmed electrical stimulation (PES) 
to induce VT and detailed 3D-electroanatomical mapping (EAM) during sinus rhythm. 
All patients were treated according to the standard clinical protocol and provided 
informed consent. 
After venous puncture PES was performed using 3 drive CL (600, 500 and 400ms) with 
up to 3 extrastimuli (down to 200ms or refractory period) and rapid pacing from at least 2 
consecutive RV sites, one close to the infundibular septum before and during isoproterenol 
infusion (2-10 micrograms/min). EAM (Thermocool catheter; Biosense Webster, Inc, Diamond 
Bar, CA) could be performed using the same venous access (using the QRS as reference for 
substrate mapping during sinus rhythm and VT activation mapping). All contact points were 
saved together with local electrograms characteristics (peak-to-peak bipolar amplitude and 
local activation time, defined as sharp peak deflection of the local bipolar electrograms that 
coincides with the maximum down stroke of the local unipolar signal) and displayed color-
coded for local voltages or activation sequences on a shell of the RV. At low amplitude sites 
(<1.5mV), pacing was performed with high output (10-mA/2ms). Sites with pacing threshold 
>10mA were considered unexcitable tissue due to surgical scars and patch material which 
together with valve annuli can form the boundaries of 4 potential anatomical isthmuses 
(figure 1A).10-12 
According to the clinical presentation and the results of PES patients were assigned to 
group 1 (no spontaneous VT, not inducible for VT), group 2 (no spontaneous VT, inducible for 
VT) and group 3 (spontaneous VT).
Characterization of anatomical isthmuses and its relation to ventricular 
tachycardia
Anatomical isthmuses were classified as “electroanatomical normal” if normal bipolar 
electrograms (≥1.5mV) could be continuously recorded throughout the anatomical 
isthmus connecting to normal voltage areas. For each anatomical isthmus width (shortest 
distance between unexcitable boundaries) and length (distance between the first normal 
bipolar electrogram at each side of the anatomical isthmus, referred to as isthmus entrance 
and exit electrograms or length of the unexcitable boundaries) were measured using 
the software of the 3D mapping system (CARTO XP™/CARTO 3™). The fill threshold for EAM 
of the anatomical isthmuses was set at ≤10mm and care was taken to delineate the length of 
the isthmus by recording the first normal voltage electrograms at isthmus entrance and exit. 
The conduction time through the isthmus during sinus rhythm was defined as the difference 
between the local activation time at isthmus entrance and exit (figure1B-C). The conduction 
velocity index (CVi) was calculated (length/conduction time). Examples of electroanatomical 
mapping data are provided in figure 2. 
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Figure 1. Panel A: Schematic overview of the 4 potential anatomical isthmuses (blue brackets), isthmus 
1 bordered by tricuspid annulus (TA) and right ventricular outflow tract patch/right ventricular incision, 
isthmus 2 by right ventricular incision and pulmonary valve (PV), isthmus 3 by PV and VSD-patch, 
isthmus 4 by VSD-patch and TA. Panel B: Schematic activation of the right ventricle during SR displayed 
as colour coded isochronal (10ms) map from red (early activation) to purple (latest activation). Panel C: 
Enlarged views of anatomical isthmus 1 (left) and 3 (right) with corresponding electrograms recorded 
from sites I-II-III, as indicated. Isthmus width, distance between unexcitable anatomical boundaries; 
Isthmus length, distance between normal electrograms (I and III) recorded at entrance and exit site of 
the anatomical isthmus. Conduction time through the anatomical isthmus, difference in local activation 
time between the entrance and exit of the anatomical isthmus. Conduction velocity index (CVi) 
calculated as indicated. EGM, electrogram; RVOT, right ventricular outflow tract; RV, right ventricular; 




Figure 2. Electroanatomical assessment of anatomical isthmus 1 (between tricuspid annulus  (TA) and 
right ventricular (RV) incision), isthmus 2 (between RV-incision and pulmonary valve) and isthmus 3 
(between pulmonary valve (PV) and VSD-patch). On the left, an example of electroanatomical normal 
isthmuses 1 and 2 in a patient without inducible VT. Upper panel: Normal bipolar EGMs with a peak-
to-peak amplitude of ≥1.5mV recorded from isthmus 1 (site II) and isthmus 2 (site I). Lower panel: 3D 
electroanatomical reconstruction of the RV (anterior view) displayed as color-coded voltage map (left, 
purple indicates normal voltages) and activation map (right, red indicates early activation, purple late 
activation). The grey tags (electrically unexcitable scar) correspond to a previous RV-incision (marked 
with the white line). Isthmus 1 had a width of 46mm (TA to RV-incision) and a length of 10mm, isthmus 
2 a width of 37mm (RV-incision to PV) and length of 27mm. On the right, isthmus 3 of a patient with 
inducible VT (cycle length 250 msec) is shown. Upper panel: EGMs recorded through isthmus 3 (sites 
A-B-C-D) are shown as indicated. The first and last EGM (A&D) are ‘normal’, the second and third EGM 
(B&C) are ‘abnormal’ (<1.5mV). Lower panel: 3D electroanatomical reconstruction of the RV (posterior 
view) displayed as voltage map and activation map. The grey tags correspond with the VSD-patch. 
Isthmus 3 (delineated by the white dashed line) had a width of 12mm and length of 27mm. The time 
interval between A to D was 62ms resulting in a conduction velocity index of 0.44m/s. Isthmus 3, was 
related to the induced VT based on pace-mapping. EGM, electrogram; PV, pulmonary valve; RV, right 
ventricle; TA, tricuspid annulus; VSD, ventricular septal defect; VT, ventricular tachycardia. 
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Normal values for CVi were derived from 12 patients without structural heart disease 
referred for right ventricular mapping and ablation of idiopathic premature ventricular 
contraction (PVCs). 
For each induced VT the critical part of the VT re-entry circuit and its spatial relationship 
to the identified anatomical isthmus was determined by either pace-mapping (at 2mA/2ms 
up to 10mA/2ms until capture) within the isthmus (>11/12 ECG-lead match between VT-QRS 
and paced QRS) or by activation mapping and/or termination of VT by radiofrequency (RF) 
ablation, if VT ablation was indicated. Before ablation, a second venous access was obtained 
for a steerable quadripolar RV catheter. Ablation was considered successful if conduction 
through the corresponding anatomical isthmus was blocked after RF delivery and VT was 
no longer inducible.10, 11 In selected patients in whom pulmonary valve replacement (PVR) 
was recommended intraoperative cryoablation of the VT related anatomical isthmus was 
performed. In patients without ICD at presentation an ICD was implanted according to 
current guidelines.20
Isthmus characteristics were compared between groups to identify those isthmuses that 
constitute an arrhythmogenic substrate. In a second step we compared the occurrence of 
spontaneous VT during follow-up between patients without an arrhythmogenic isthmus 
at baseline or after ablation (group A) and patients discharged with an arrhythmogenic 
isthmus (group B). 
Follow-up 
Patients were followed at the Grown-Up Congenital Heart Disease outpatients’ department 
and/or the arrhythmia service according to institutional protocols. Follow-up started at 
electrophysiological evaluation or (if performed) ablation. Mortality was assessed from 
hospital records.
Statistical analysis 
Continuous data are reported as median with inter quartile range (IQR) or mean ± standard 
deviation (SD) according to data distribution. Categorical data are presented as percentage 
or frequencies. Differences between the 3 groups were assessed by 1-way ANOVA with 
post-hoc testing, Kruskal-Wallis and Chi-Square test where appropriate. The properties of 
VT related anatomical isthmuses and anatomical isthmuses of patients without VT were 
compared using a Chi-Square or Mann-Whitney U test where appropriate and were illustrated 
with a dot plot. To determine the association between the presence of an arrhythmogenic 
isthmus and clinical variables (age of repair, time after repair, gender, transannular-
patch, syncope, QRS-duration, nsVT on Holter and RV/LV function), odds ratios including 
95% confidence intervals were estimated using uni and multivariable logistic regression. 
The occurrence of VT during follow-up was compared for group A (patients without an 
arrhythmogenic isthmus at baseline or after ablation) and group B (patients discharged 
with an arrhythmogenic isthmus) using a Log-Rank test. SPSS 20.0 for Windows was used. 






Seventy-four patients (age 40±16 years, 64% male) repaired at a median age of 5.9 years 
(2.3–11.8) were included; in 44 (59%) biventricular function was preserved. Twenty-eight 
(38%) patients had one, 29 (39%) two, and 17 (23%) ≥3 risk factors for VT; thirteen patients 
had a documented VT. During PES 28 patients, including all 13 with prior VT, were inducible 
for 41 VTs [median of 1 (1–2), VTCL 252msec (231–312)]. Patient characteristics according to 
clinical presentation and the results of PES are summarized in table 1. 
Presence and characteristics of anatomical isthmuses according to groups
In all patients at least one anatomical isthmus could be identified during SR (69±14 bpm) 
in 70 patients or RV-pacing in 4 patients (table 2). An electroanatomical abnormal isthmus 
(bipolar voltages <1.5mV) was found in 26 of 28 patients with inducible VT, but in only 5/46 
patients without VT. Anatomical isthmuses of patients with clinical and/or induced VT were 
on average 8 mm (95% CI 3–13, p=0.002) narrower and 6 mm (95% CI 2–9, p=0.001) longer 











Age, y 35.1±14.7 42.8±12.4 52.3±14.8* 0.001
Male, n (%) 28 (61%) 10 (67%) 9 (69%) 0.824
Age at repair, y 5.3 (2.0-6.9) 5.5 (1.7-16.3) 13.4 (5.8-19.8)* 0.005
Age at repair ≥5y 25 (54%) 9 (60%) 11 (85%) 0.142
TA-patch 19/39 (49%) 7 (47%) 5/11 (46%) 0.978
Time after repair, y 29.5±11.1 33.5±8.7 36.9±9.4 0.062
PVR 8 (17%) 6 (40%) 4 (31%) 0.174
Age at PVR age, y 30.6±10.4 40.9±15.9 26.1±11.0 0.181
Syncope 3 (7%) 1 (7%) 1 (8%) 0.989
QRSd non-paced, ms 155±25 161±25 149±32 0.510
QRSd ≥180ms 6/44 (14%) 3/13 (23%) 2/11 (18%) 0.705
Non-sustained VT 12/41 (29%) 3/11 (27%) 3/7 (43%) 0.745
ICD carrier 1 (2%) 1 (7%) 4 (31%)* 0.004
LV function 
 Good/mildly depressed 46 (100%) 14 (93%) 11 (85%)* 0.039
 Moderately/severely depressed 0 (0%) 1 (7%) 2 (15%)
RV function
 Good/mildly depressed 28 (61%) 9 (60%) 7 (54%) 0.900
 Moderately/severely depressed 18 (39%) 6 (40%) 6 (46%)
Preserved cardiac function, n (%) 28 (61%) 9 (60%) 7 (54%) 0.900
Risk factor, n 2.0 (1.0-2.0) 2.0 (1.0-2.0) 2.0 (2.0-3.0) 0.085
LV, left ventricle; PVR, pulmonary valve replacement; QRSd, QRS duration; RV, right ventricle; TA, transannular; VT, 
ventricular tachycardia; y, year. *P<0.01 vs controls. 
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compared to anatomical isthmuses of patients without VT. The most prominent difference 
in isthmus characteristics was the conduction velocity index, which was significantly lower 
in patients with clinical and/or induced VT (0.36±0.34 versus 0.78±0.24, p<0.001). Notably, 
there was no significant difference in isthmus length, width and conduction velocity index 
between patients with only inducible VT (group 2) and patients with spontaneous VT 
(group 3). Conduction velocity index was not related to age (additional data is provided in 
supplemental B1). Detailed data for each anatomical isthmus is provided in supplemental 
B2. No mapping related complications occurred.
Conduction velocity index in controls
CVi were calculated from 142 adjacent RV outflow tract sites (distance between sites 22±9 
mm) in 12 patients (age 41±13 years, 33% male) without structural heart disease. The average 
CVi during SR (67±10 bpm) was 1.24±0.32 m/s (range 0.52-1.89 m/s) with 95% of all CVi 
>0.56 m/s. The slowest CVi in controls were measured in a control with right bundle branch 
block (0.92±0.43 m/s, range 0.52-1.68 m/s). Based on these findings a CVi <0.5m/s was 
considered abnormal. 
Characteristics of VT related anatomical isthmuses 
Thirty-seven of 41 induced VTs were related to an anatomical isthmus; twenty-four VTs in 
17 patients were mapped to isthmus 3, 10 VTs in 8 patients to isthmus 1, 2 VTs in 2 patients 
to isthmus 2 and 1 VT to isthmus 4. Twenty patients had only one VT related anatomical 
isthmus and four patients had 2 VT related anatomical isthmuses each supporting different 
VT re-entry circuits. VT related anatomical isthmuses were significantly longer and tended 
to be narrower than isthmuses in patients without VT (figure 3). All VT related anatomical 
isthmuses were electroanatomical abnormal and slow conducting with a CVi of <0.5 m/s 
(slow conducting or arrhythmogenic anatomical isthmus). Such a slow conducting 
anatomical isthmus (SCAI) was only found in 2 patients of group 1. 
Four VTs in 4 patients could not be related to an anatomical isthmus. In two patients, both 
with advanced heart failure and poor RV function and no SCAI, the VT substrate was related 










Isthmus, n 2.0 (1.0-2.0) 2.0 (2.0-3.0) 2.0 (2.0-3.0) 0.111
Minimal width, mm 28±11 22±10 18±5* 0.005
Maximal length, mm 16±7 20±7 25±7* 0.001
EA abnormal isthmus, n pts 5 13* 13* <0.001
Lowest CVi, m/sec 0.78±0.24 0.44±0.44* 0.27±0.09* <0.001




to a large free wall scar (n=1) and likely due to a focal VT mechanism (n=1). In two patients 
with an arrhythmogenic isthmus sufficient mapping could not be performed to prove 
the relation of the induced VT to an identified slow conducting isthmus due to procedural 
reasons. The sensitivity and specificity of a slow conducting AI (SCAI) with CVi<0.5 m/s to 
predict AI related VT was 93% and 100%, respectively.
Figure 3. Aligned dot plot. CVi, conduction velocity index; number 1-4 indicate anatomical isthmus 1-4; 
VT, ventricular tachycardia; VT -, isthmus not critical for VT; VT+, isthmus critical for VT
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Association between risk factors and arrhythmogenic isthmuses 
On univariable analysis, age at repair (OR 1.07 (1.00-1.15)/year, p=0.037) and time after repair 
(OR 1.06 (1.01-1.11)/year, p=0.029) were associated with the presence of a slow conducting 
anatomical isthmus. In multivariable analyses, none of the variables remained associated 
with a SCAI. Additional information is provided in table 3. 
Ablation targeting arrhythmogenic anatomical isthmuses
Sixteen of 26 patients with an arrhythmogenic isthmus related VT and the two patients with 
a slow conducting isthmus but without induced VT underwent successful isthmus ablation. 
A total of 62 patients (44 without arrhythmogenic anatomical isthmus at baseline, 18 after 
successful isthmus ablation) were discharged without slow conducting isthmus (group A). In 
the remaining 10/26 patients (group B) with an arrhythmogenic isthmus and VT, VT-ablation 
was not successful (n=8) or not performed (n=2). The 2 patients with heart failure and 
inducible VT that were not related to an anatomical isthmus (group C) underwent ablation, 
which was successful in one. Eighteen patients (49±14 years, 72% male) received an ICD 
before discharge; in 6 patients VT-ablation has failed and was not performed in 2. In additional 
6 patients an ICD was implanted despite procedural success because of a depressed cardiac 
function (n=2) or patients preference. The remaining 4 patients received an ICD because of 
a depressed cardiac function (n=3) and a prior out-of-hospital cardiac arrest (n=1).
Follow-up
Patients were followed for a mean of 50±22 months. All 63 patients without a slow conducting 
isthmus at discharge remained free from VT (group A). Five out of ten patients with a failed 
ablation of an arrhythmogenic, slow conducting isthmus (group B) experienced 1≥ episodes 
of VT (all terminated with ICD therapy), figure 4. The difference between group A and B was 




Univariate odds ratio (95% CI)
 
p
Gender (male) 1.06 (0.40-2.81) 0.914
Age at repair, per year ↑ 1.07 (1.00-1.15) 0.037
Time after repair, per year ↑ 1.06 (1.01-1.11) 0.029
TA-patch 0.79 (0.29-2.14) 0.638
Syncope 1.10 (0.17-7.04) 0.918
QRS duration (ms) 1.00 (0.98-1.02) 0.858
nsVT on Holter 1.74 (0.54-5.61) 0.357
RV function depressed 0.92 (0.35-2.40) 0.864
LV function depressed Indefinite
Risk factor 1.21 (0.73-1.99) 0.460
LV, left ventricular; ms, milliseconds; nsVT, non-sustained VT; TA-patch, transannular patch; VT, ventricular 




significant (p<0.001). Three patients died during follow-up, two due to terminal heart failure 
one due to cancer. No sudden cardiac death occurred.
DISCUSSION
To the best of our knowledge, this is the first study to present substrate identification for VT 
in patients with rTOF with the potential for individualized risk stratification and immediate 
tailored treatment. We found that slow conducting anatomical isthmuses (<0.5m/s) were 
the substrate for all documented and induced ventricular tachycardia in rTOF with preserved 
cardiac function. This substrate could not be predicted by previously suggested clinical risk 
factors. Repaired TOF patients without an arrhythmogenic, slow conducting anatomical 
isthmus at baseline or after successful isthmus ablation were free of VT during a mean 
follow-up of 50±22 months. 
Ventricular arrhythmias in repaired Tetralogy of Fallot
The majority of arrhythmias documented in young to middle-aged patients with rTOF 
are fast but monomorphic VTs, which is in line with the short median VTCL of 252 msec 
(231–312) observed in our cohort.9 These arrhythmias are likely to be fatal if untreated, 
even in patients with good biventricular function. Of concern and importance, two-
thirds of rTOF patients that die suddenly, typically also early to middle-aged adults, have 
preserved cardiac function and good functional status prior to the event, comparable with 
our study population, supporting non-heart failure related arrhythmia mechanisms.4, 5 
Clinical parameters have been associated with VT and sudden cardiac death but the predictive 
value is limited and may not apply to the current rTOF population with earlier and improved 
Figure 4. AAD, antiarrhythmic drugs; FU, follow-up; ICD, internal cardiac defibrillator; Pt(s), patient(s); 
Ablation+, complete successful ablation; Ablation-, no complete successful ablation; VT, ventricular 
tachycardia; †, no ICD because of physician preference; ‡, no ICD because of mental disability; *, heart 
failure; **, cancer
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surgical interventions.7 Identification of the VT substrate in an individual patient may allow 
individualized risk stratification and substrate based treatment.
Substrate for ventricular tachycardia
Mapping studies in patients with rTOF and spontaneous VT have demonstrated that 
the substrate is typically located in anatomically defined isthmuses.10-12 Anatomical 
isthmuses are the result of the malformation and the type of repair and were present in 
all rTOF patients in our cohort. In our study, anatomical isthmuses 1 and 3 were the most 
prevalent anatomical isthmuses. Isthmus 3 was the narrowest isthmus, which is in line with 
the observation in postmortem specimen of rTOF.21 Of interest, anatomical isthmus 3 as 
compared to the other isthmuses was more often electroanatomical abnormal and more 
often related to VT. In the postmortem histological analysis isthmus 3 had the highest 
degree of fibrosis thereby providing the potential histological substrate for slow conduction. 
We could demonstrate that specific electroanatomical isthmus characteristics, in particular 
the conduction velocity index through an anatomical isthmus are the key determinants for 
VT. All VT related anatomical isthmuses had an abnormal, low conduction velocity index of 
<0.5 m/s. 
Patients without a slow conducting isthmus at baseline or after ablation remained VT 
free during a follow-up of 262 patient years. Reported arrhythmia event rates in patients 
with similar clinical risk factors who have received ICDs for primary or secondary prevention 
ranged between 8 to 10% per year, which is comparable with the event rate in patients 
discharged with an arrhythmogenic isthmus.9 These findings further support the strong link 
between slow conducting isthmuses and arrhythmia events.
Risk stratification in the modern era
The progress in surgical techniques from a classical transventricular to a transatrial-
transpulmonary approach affects presence and geometry of the anatomical isthmuses 1 
and 2. However, isthmus 3 between the ventricular septal defect patch and the pulmonary 
valve is not prevented by current surgical techniques. This isthmus was present in 14 of 
the 15 patients in our cohort corrected within the first two years of life. Of importance, 
despite early repair, isthmus 3 was slow conducting in 5 (33%) and related to VT in 4 (27%) of 
these patients. 
The proposed method of substrate identification using a non-fluoroscopic mapping-
system requires a single venous access and can be applied for individualized VT risk 
stratification with minimal radiation exposure. This is especially valuable for patients with 
preserved cardiac function and no competing arrhythmia mechanism, who, importantly 
constitute the majority of the rTOF population. In patients with an arrhythmogenic isthmus 
preventive ablation may be considered, which can be performed during the same procedure 
or intraoperatively for those who require a second surgical interventions for pulmonary valve 




3 (n=3) and the presence of a pulmonary homograft covering isthmus 3 (n=2). Repaired TOF 
patients without an arrhythmogenic isthmus at baseline or after successful isthmus ablation, 
in the presence of a preserved biventricular function, may not require ICD implantation.
Limitations
The current study is limited by sample size, although, to our knowledge, this is the largest 
cohort of rTOF patients that underwent VT induction and electroanatomical mapping to 
date. Our study is also limited by a mean follow-up of 50±22 months, although supporting 
evidence is provided that conduction velocity of the majority of anatomical isthmuses may 
not change during follow-up. Wider anatomical isthmuses with preserved myocardium 
and normal voltages are unlikely to change conduction properties, which were not age 
dependent in our cohort, provided that cardiac and valvular functions remain stable. In 
contrast, narrower isthmuses with abnormal voltages may need re-mapping or may even 
justify preventive isthmus ablation in particular if CVi are low. However, sequential mapping 
was not performed to evaluate isthmus characteristics over time.  
Studies with longer follow-up to further validate the concept are desirable. This study has 
been performed in high volume tertiary referral centres with expertise in electrophysiological 
evaluation of patients with congenital heart disease, which likely influences the characteristics 
of the patient population. Furthermore, contact force catheters became available only 
during the course of the study and were therefore used in the minority of patients. Without 
contact force measurement some sites with low voltage and no-capture due to poor contact 
may have been tagged as unexcitable tissue thereby underestimating isthmus widths.
CONCLUSION
In rTOF, slow conducting anatomical isthmuses are the dominant substrate for VT and can be 
identified by electroanatomical mapping via a single venous access allowing individualized 
risk stratification and tailored treatment.
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Electrophysiological evaluation of patients with repaired Tetralogy of Fallot with documented 
ventricular arrhythmias (VA) or considered at risk for VA referred to the Electrophysiology 
service for diagnostic testing, risk stratification or treatment.
1. Background
Tetralogy of Fallot (TOF) is associated with late morbidity and mortality due to ventricular 
arrhythmias (VA).1, 2 The majority of VA are sustained monomorphic ventricular tachycardias 
(MSVT).3 These VTs are often fast and require ICD shocks in patients who have received an 
ICD for primary or secondary prevention.3 In patients without ICDs fast VTs may be fatal even 
in the presence of a preserved RV and LV function. Of concern, two thirds of repaired TOF 
(rTOF) patients who died suddenly or have experienced a life threatening VT had a preserved 
biventricular function before the first event.4, 5 It is therefore of utmost importance to identify 
patients at risk for VT and sudden cardiac death (SCD). Several risk factors (RF) have been 
identified associated with VT and/or SCD, however with limited predictive value.
Reported RF include: syncope, QRS duration ≥180ms, non-sustained VT on Holter, at least 
moderate dysfunction of the left ventricle (LV) or right ventricle (RV), late repair (≥5years 
of age), presence of a transannular patch (TA-patch) and extensive ventricular fibrosis on 
(CE)-CMR.6-13
Prophylactic implantation of ICDs is still under debate. According to current guidelines, 
primary prevention ICD implantation is considered reasonable in selected adults with rTOF 
and multiple risk factors for SCD, such as left ventricular systolic or diastolic dysfunction, 
nonsustained VT, a QRS duration greater than 180ms, extensive right ventricular scarring, 
or inducible sustained VT at electrophysiological study.14 If symptoms of presyncope or 
syncope are reported, an induction protocol for both VT and supraventricular tachycardias is 
considered to be helpful. However, not all rTOF patients that experience VT during follow-up 
and had undergone programmed electrical stimulation prior to ICD implantation have been 
inducible in the EP lab.15 These data suggest that programmed electrical stimulation alone 
may not be sufficient to proof the presence of a substrate for VT in all patients.
The majority of VT in rTOF is due to macroreentry with critical VT isthmus sites located 
within anatomically defined regions.16 These anatomical isthmuses can be identified 
during stable sinus rhythm facilitated by 2D electroanatomical mapping systems and 
immediately targeted by radiofrequency catheter ablation in the lab or by surgical ablation 
in those who are considered for re-operation.17 In prior mapping and ablation studies it 
has been demonstrated that VT related anatomical isthmuses often show characteristics 
consistent with slow conduction, which is an important pre-condition for reentry VT. In 
a series of adults with repaired congenital heart disease (majority rTOF) who underwent 
VT ablation, complete procedural success has been defined as non-inducibility of any VT 




none of the patients in whom complete procedural success was achieved had recurrence of 
a monomorphic VT during long term follow-up. These data further support the strong link 
between “arrythmogenic” anatomical isthmuses and macroreentrant VTs. Although almost 
all rTOF patients have anatomically defined isthmuses, not all are related to VT or may serve 
as a potential substrate for VT. 
To improve both risk stratification and identification of the potential VT substrate in 
an individual patient with rTOF with VT or who is considered at risk for VA, programmed 
electrical stimulation and right ventricular electroanatomical mapping has been included in 
our routine clinical protocol for risk assessment in patients after repair of TOF.
2. Patients eligible for the protocol
All rTOF patients who are referred for electrophysiological evaluation and/or for treatment 
of ventricular arrhythmias, who had documented VT or who are considered at risk for VT. 
Other eligible patients for the protocol are pre-operative patients prior to pulmonary 
valve replacement.
After complete non-invasive evaluation (ECG, Holter, exercise test, imaging studies 
(echocardiogram, contrast enhanced (CE)-MRI) on the discretion of the referring GUCH 
cardiologist), all eligible patients are presented and discussed during our weekly conference 
in the presence of GUCH cardiologist, Electrophysiologist and Congenital surgeon. 
Repaired TOF patients are considered at risk when at least one of the following risk factors 
is present:6-13
I. (Pre)Syncope
II. QRS duration ≥180ms
III. Non-sustained VT on Holter
IV. Moderate dysfunction of the left ventricle
V. Moderate dysfunction of the right ventricle
VI. Late repair (≥5years of age)
VII. Presence of a transannular patch
VIII. Extensive ventricular fibrosis on (CE)-CMR
3. Electrophysiological evaluation and ablation
All patients are informed in advance regarding the potential outcome of 
the electrophysiological evaluation and the potential treatment options (catheter ablation, 
ICD implantation, surgical ablation, if appropriate). All patients have to provide oral informed 
consent prior to the procedure, which is documented in the medical chart.
VT induction and electroanatomical mapping
Programmed ventricular stimulation and electroanatomical right ventricular mapping 
(EAM) are performed in a non-sedated and post absorptive state using a single venous 
sheath (8 French, modified Seldinger Technique). Heparine bolus is administered via 
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the venous sheath and heparine is administrated during the procedure to maintain an ACT 
250-300. A quadripolar catheter is inserted in the RV to perform standard programmed 
electrical stimulation (PES). PES consists of three drive cycle lengths (600, 500 and 
400ms) with up to 3 ventricular extrastimuli (CL≥200ms) and burstpacing, from the RV 
apex and the RVOT which will be repeated with isoprotenerol (2-10µg/min) if necessary. 
Electroanatomical voltage and activation mapping is performed during sinus rhythm (SR) or 
RV pacing in patients who are pacemaker dependent using a non-fluoroscopic 3D mapping 
system using a single venous access. Surface QRS is used as reference for substrate mapping 
during SR. An electroanatomical reconstruction of all anatomical isthmuses is obtained by 
identification of the anatomical border as previously described.16, 17 After completion of 
the voltage and activation maps characteristics of each anatomical isthmus are assessed 
(electrograms characteristics, activation sequence consistent with conduction delay) to 
identify those anatomical isthmuses likely related to VT. 
Patients inducible for MSVT
For each induced VT the critical part of the VT re-entry circuit and its spatial relationship to 
the identified anatomical isthmus is determined by either pace-mapping (at 2mA/2ms up 
to 10mA/2ms until capture) within the isthmus (>11/12 ECG-lead match between VT-QRS 
and paced QRS) or by activation mapping and/or termination of VT by radiofrequency (RF) 
ablation, if VT ablation is indicated.
Patients inducible for MSVT related to an anatomical isthmus 
After VT mapping and after the identification of an anatomical isthmus related to VT, ablation 
will be offered and performed during the same procedure (as discussed with the patient 
before the procedure). Before ablation, a second venous access has to be obtained for 
a steerable quadripolar RV catheter allowing for pacing at both sides of the targeted 
anatomical isthmus. Endpoint of RF ablation is defined as non-inducibility of VT and 
bidirectional isthmus conduction block.
Patients inducible for MSVT or patients not inducible for MSVT but with abnormal 
anatomical isthmuses (slow conduction) during sinus rhythm scheduled for  
re-operation
In patients in whom pulmonary valve replacement is recommended intraoperative 
cryoablation of the VT related anatomical isthmus will be performed. Preventive ablation 
of a potentially arrhythmogenic isthmus will be considered and discussed with the patient.
Post-procedural protocol
The venous sheath(s) is(are) removed in the cathlab. Routine control of the vascular access 
site is performed in the lab and 4 hours later on the ward. All patients who underwent 
ablation receive an echocardiogram the next day before discharge. If patients meet the ESC 
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Supplement B1. Association between age and the conduction velocity index of the slowest 
anatomical isthmus
Conduction velocity, m/s  
odds ratio (95%, CI) p
VT+
 Age, per year ↑ -0.001 (-0.010 – 0.009) 0.901
VT-
 Age, per year ↑ -0.003 (-0.008 – 0.002) 0.271
Control group
 Age, per year ↑ -0.006 (-0.015 – 0.004) 0.196
CI; confidence interval; VT, ventricular tachycardia; VT-, no spontaneous/inducible VT; VT+, spontaneous and/or 
inducible VT. 










Isthmus 1 40 (87%) 14 (93%) 13 (100%) 0.335
 EA abnormal 0 3** 6** <0.001
 Width (mm) 44±10 37±8 35±14 0.017
 Length (mm) 12±4 13±6 18±8** 0.003
 CVi (m/sec) 1.11±0.34 0.90±0.48 0.69±0.32** 0.002
Isthmus 2 11 (24%) 4 (27%) 4 (31%) 0.878
 EA abnormal 0 1 4** † 0.001
 Width (mm) 30±12 25±14 25±10 0.648
 Length (mm) 13±5 17±8 27±3** 0.004
 CVi (m/sec) 0.95±0.32 0.78±0.27 0.40±0.09* 0.015
Isthmus 3 38 (83%) 13 (87%) 13 (100%) 0.269
 EA abnormal 5 11** 12** <0.001
 Width (mm) 26±8 21±6 20±6 0.043
 Length (mm) 16±8 20±7 20±7 0.101
 CVi (m/sec) 0.80±0.29 0.40±0.21** 0.29±0.14** <0.001
Isthmus 4 0 (0%) 4 (27%)** 0 (0%) † <0.001
 EA abnormal 2
 Width (mm) 19±5
 Length (mm) 16±7
 CVi (m/sec)   0.72±0.67    
CVi, conduction velocity index; EA, electroanatomical; Pts, patients; SMVT, sustained monomorphic ventricular 
tachycardia; *, P<0.05 vs SMVT-;**, P<0.01 vs SMVT-; †, P<0.05 vs SMVT inducible.
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Ventricular tachycardia (VT) is an important cause of late morbidity and mortality in repaired 
congenital heart disease (rCHD). The substrate often includes anatomical isthmuses that can 
be transected by radiofrequency catheter ablation (RFCA) similar to isthmus block for atrial 
flutter. This study evaluates the long-term efficacy of isthmus block for treatment of reentry 
VT in adults with rCHD. 
Methods and Results
Thirty-four patients (49±13 years, 74% male) with rCHD who underwent RFCA of VT in 
two centres were included. Twenty-two (65%) had a preserved left and right ventricular 
function.  Patients were inducible for 1 (IQR 1-2) VT, median cycle length 295ms (IQR 
242-346). Ablation aimed to transect anatomical isthmuses containing VT reentry circuit 
isthmuses. Procedural success was defined as non-inducibility of any VT and transection of 
the anatomical isthmus and was achieved in 25 (74%) patients. During long-term follow-up 
(46±29 months) all patients with procedural success (18/25 with ICDs) were free of VT 
recurrence but 7/18 experienced ICD related complications. One patient with procedural 
success and depressed cardiac function received an ICD shock for VF. None of the 18 patients 
(12/18 with ICDs) with complete success and preserved cardiac function experienced any 
ventricular arrhythmia. In contrast, VT recurred in 4/9 patients without procedural success. 
Four patients died from non-arrhythmic causes.
Conclusions
In patients with rCHD with preserved ventricular function and isthmus dependent reentry, 
VT isthmus ablation can be curative. 




The population of adults with repaired congenital heart disease (rCHD) is growing as 
improved surgical techniques are extending survival.1 However, rCHD is still associated with 
late morbidity and mortality due to ventricular arrhythmias (VA).2, 3 Ventricular arrhythmias 
encompass polymorphic ventricular tachycardia (PVT), ventricular fibrillation (VF) and 
monomorphic ventricular tachycardia (MVT) with potentially different underlying substrates 
requiring different treatment strategies. Patients who experience any VA are considered 
candidates for internal cardiac defibrillator (ICD) implantation for prevention of sudden 
cardiac death (SCD).4 ICDs, however do not prevent VA and are frequently associated with 
device related complications and inappropriate therapy in rCHD.5-7 An important option 
to prevent MVT is radiofrequency catheter ablation (RFCA)8, 9, which may be considered 
as alternative to ICDs in patients with an otherwise low risk for SCD.10 In scar-related VTs, 
non-inducibility has often been used as procedure endpoint, and has not been a reliable 
predictor of freedom from VT during follow-up.11 MVT in adults with rCHD often depends 
on well-defined anatomical isthmuses.8, 9 These isthmuses can be transected by RFCA and 
demonstration of conduction block provides a defined procedural endpoint similar to that 
for achieving block in the common right atrial flutter isthmus. We hypothesized that this 
isthmus ablation approach may be sufficiently reliable for ablation to be considered as 
sole therapy for selected patients with VT due to rCHD.9 The aims of the current study were 
(I) to evaluate the acute and long-term efficacy of isthmus ablation for treatment of VT in 
a large population of adults with rCHD and (II) to identify patients in whom RFCA may be an 
alternative to ICD therapy. 
METHODS
Patient Population 
The series consisted of consecutive patients with rCHD, who underwent RFCA of VT aiming 
to target anatomical isthmuses in two centers (Brigham and Women’s Hospital, Leiden 
University Medical Center) between 2001 and 2012. The medical records of all patients 
were reviewed for type of malformation, surgical history, device implantation, presenting 
symptoms, documented arrhythmias and medication at referral. Non-paced 12-lead ECGs 
recorded at admission were analyzed for QRS duration. The occurrence of non-sustained 
VT (≥3 consecutive beats, rate >120 beats/min, lasting <30s) was captured from Holter 
recordings. The review of medical records was approved by the hospital human subject 
protection committee. Nine patients were included in our initial report 7 years ago.9
Hemodynamic evaluation before ablation
Echocardiographic and cardiac magnetic resonance imaging (CMR) studies performed prior 
to ablation were collected. The echocardiographic studies were reviewed by an independent 




was semi-quantitatively assessed and classified as poor, moderately reduced, mildly reduced 
or good.12, 13 Tricuspid annular plane systolic excursion (TAPSE) was measured but not used 
in case of tricuspid valve annuloplasty. Mildly reduced or good RV function with a TAPSE≥14 
mm was considered as preserved. The LV ejection fraction was assessed by Simpson’s method 
and classified as poor (<30%), moderately reduced (30-39%), mildly reduced (40-54%) or 
good (≥55%). LVEF≥40% was considered preserved LV function. If available, cardiac volumes 
and volume derived parameters were evaluated by CMR. In case of discrepancy CMR results 
determined the definitive classification. Designation of preserved cardiac function required 
both preserved RV and LV function.
Electrophysiology Study, Electroanatomical Mapping and Ablation 
Programmed electrical stimulation (PES) was performed from the RV apex and RVOT with 
3 extra stimuli at 3 basic cycle lengths (CL) including administration of isoproterenol. 
The method to obtain a 3D reconstruction of all specific anatomic isthmuses and targeting 
the VT related isthmus by ablation has been previously described in detail.9 Briefly, 3D 
RV and/or LV electroanatomical bipolar voltage mapping during SR or RV pacing was 
performed using a venous and/or retrograde access. In transposition of the great arteries 
(TGA), the morphological right ventricle was approached via the aorta in the case of an 
atrial switch and via venous access in the case of an arterial switch operation.To identify 
prosthetic material adjacent to normal myocardium and surgical scars high output pacing 
was performed at all low voltage sites (<1.5mV). Sites with a pacing threshold >10mA were 
tagged as electrically unexcitable scar (EUS).14 
Tricuspid and mitral annulus were identified by atrial and ventricular electrograms of 
approximately equal amplitudes. Areas of EUS (e.g. incisions, patch material) and valve 
annuli were considered to be boundaries of anatomical isthmuses. The critical re-entry 
circuit isthmus of each induced VT was determined by diastolic activity and slowing or 
termination during RF delivery and/or entrainment during VT and/or by pace-mapping 
(pace-match >10/12 leads).9, 14 If the critical isthmus site was located within an anatomically 
defined isthmus the anatomical isthmus was considered “critical” and the adjoining 
anatomical boundaries were connected by a linear RF lesion. RF ablation was performed 
with an open saline-irrigated catheter (power limit, 50W) in 32 patients (Thermocool) or 
an 8-mm-tip catheter (power limit, 70W) in 2 patients. In all studies high output pacing 
(10mA, 2ms) along the line was performed and no capture was considered as a transected 
anatomical isthmus. Block was further supported by the presence of double potentials and/
or a change in activation sequence during SR or RV-pacing after ablation (figure 1). More 
recently differential pacing was performed to confirm bidirectional conduction block. After 
transection of the anatomical isthmus programmed stimulation was repeated.
Complete procedural success was defined as non-inducibility of any VT and transection 
of the critical anatomical isthmuses; partial success, if only non-clinical VTs could be 
induced and/or transection of the corresponding anatomical isthmus of the non-clinical 
VT could not be performed and/or no potential re-entry circuit site for a non-clinical VT 
VT Ablation in Congenital Heart Disease
47
3
Figure 1. Procedural workflow. Panel A: 12-lead VT-ECG recorded during resuscitation. Panel B: Induced 
clinical VT. Panel C: Bipolar voltage and activation map during sinus rhythm (modified PA-view). Voltage 
and activation time is color-coded according to bar, gray tags indicate unexcitable tissue. Anatomical 
isthmus 3 (white dashed brackets) is present between the VSD-patch and the pulmonary valve (PV) 
with continuous conduction. Panel D: VT isthmus site within anatomical isthmus 3 is identified by pace-
mapping. Panel E: Voltage and activation map after ablation. Red tags indicate ablation sites. After 





could be identified; failure, if the clinical or presumed clinical VT remained inducible and/
or transection of the corresponding anatomical isthmus could not be performed and/or no 
potential re-entry circuit site for a clinical VT could be identified. The procedural outcome 
was considered undetermined if the induction protocol was not repeated after ablation.
Follow-up
In patients without an ICD prior to ablation, an ICD was recommended if indicated according 
to current guidelines.4 Anti-arrhythmic drugs (AAD) were discontinued at the discretion 
of the electrophysiologist. Patients were followed according to the institutional protocol. 
All episodes of spontaneous sustained VA and appropriate and inappropriate ICD therapy 
were recorded. VT was considered sustained when ≥30 seconds or terminated by the ICD. 
Recurrence was defined as documented sustained VT and/or symptoms highly suspicious 
for sustained VA. Device related complications were registered. Mortality was assessed from 
hospital records. For patients that were not followed at the two institutes’ outside records of 
the clinical and device follow-ups were obtained.
Statistical analysis 
Continuous variables are reported as mean±standard deviation (SD) or median with 
the interquartile range (IQR), according to variable distribution and categorical variables 
as percentages and frequencies. Patients with and without complete procedural success 
were compared using Student’s t-test, Mann-Whitney U test, Chi-Square test and Log-rank 
test where appropriate. Odds and hazard ratios of gender, age (at repair), pulmonary valve 
replacement (PVR), LV function, RV function, cardiac function, number and average VT cycle 
length (VTCL) of induced VTs were calculated for acute procedural outcome, sustained MVT 
and VA occurrence during follow-up using univariate logistic regression and hazard’s Cox’s 
proportional hazard regression analysis where appropriate. The Kaplan Meier method was 
used to plot freedom of sustained MVT in patients with and without complete procedural 
success and freedom of appropriate ICD therapy and inappropriate shocks in patients with 
complete procedural success and preserved cardiac function. P value of 0.05 was considered 
significant. SPSS software (20.0 Windows, SPSS Inc, Chicago, IL) was used. 
RESULTS
Patient characteristics
The population consisted of 34 adults (25 male, 48.6±13.2years) with rCHD who had 
undergone total repair at a median age of 10.0 (IQR, 4.5-18.5) years. Twenty-eight had 
undergone repair of Tetralogy of Fallot (TOF), 2 of TGA (Mustard baffle in one, arterial switch 
operation in one), 2 of ventricular septal defect (VSD) with bicuspid aortic valve (bAV) or 
congenital pulmonary stenosis (cPS), 1 of atrioventricular septal defect (AVSD) and 1 of 
cPS. In 10 prior palliative shunting had been performed and in 13 patients initial repair was 
followed by reoperation, which was pulmonary valve replacement (PVR) in 9 at a mean age 
VT Ablation in Congenital Heart Disease
49
3
of 36±12years. At referral 14 patients (41%) had an ICD. Twenty-seven patients presented 
with spontaneous sustained monomorphic VTs (SMVT) documented on ECGs (18) and/or 
ICDs (14). In the remaining 7 patients SMVT was suspected and could be induced during 
programmed electrical stimulation. Mean QRS duration (non-paced; n=29) was 161±29msec; 
in 21% QRS duration exceeded 180 msec.
Hemodynamic characteristics
Echocardiography was performed in 32 patients and 11 had undergone CMR. In 32 patients 
imaging was performed during admission for RFCA or within the preceding 6 months. In two 
patients, imaging studies that were acquired >6 months before RFCA and after RFCA showed 
similar results suggesting stable cardiac function. In only one patient imaging results were 
discrepant (RV function moderately reduced on echocardiography, but preserved (RVEF 
41%) on CMR). RV function was preserved in 71% and LV function in 82% of the patients. 
Both RV and LV function were preserved in 22 (65%) patients (table1).
Mapping and ablation outcome
The 34 patients had 61 different VTs (median of 1 (1–2) VT/pt) inducible with a median VTCL 
of 295ms (IQR 242–346). In all patients with VT documentation the (presumed) clinical VT 
could be induced. In all 7 patients without prior VT documentation only one VT could be 
reproducibly induced and was considered the clinical VT. Mapping revealed 6 different 
anatomical isthmuses (figure 2). In all patients, at least one isthmus could be identified 
(median of 2 (2–3) isthmus/patient). Isthmus 1 was bordered by the tricuspid annulus 
(TA) and a previous RV-incision/RVOT-patch and was present in 30 patients; isthmus 2 by 
a previous RV-incision and the pulmonary valve (PV) and present in 7 patients. Isthmus 3 was 
bordered by the PV and VSD-patch, present in 30 patients and isthmus 4 was bordered by 
the VSD-patch and the TA and present in 7 patients.9 Isthmus 5 was bordered by the aortic 
root and a basal septal scar in 1 patient15 and isthmus 6 was bordered by the mitral annulus 
and a basal-posterolateral LV scar in 1 patient. In all 34 patients the anatomical isthmus 
related to the (presumed) clinical VT could be identified. In 10 patients, two or more VTs 
shared the same anatomical isthmus. Furthermore, nine patients had two anatomical 
isthmus related to different VTs (additional mapping data is provided in supplemental 
table A).  
Complete procedural success was achieved in 25 patients (21 TOF, 2 D-TGA, 1 VSD and 1 
AVSD), partial success in three (2 TOF, 1 VSD) and the procedure failed in four (TOF) patients. 
Ablation failure or partial success was likely due to the hypertrophy of the targeted anatomical 
isthmus in three TOF patients and an interposed pulmonary homograft in two TOF patients. 
In one patient (VSD) RFCA was withheld because of the proximity of the His bundle and in one 
TOF patient no critical reentry circuit site for two VTs could be identified. In two patients with 
impaired cardiac function no re-induction was performed (length of the procedure, induced 




success between rCHD patients with rTOF and without rTOF (p=0.675). Cardiac function was 
preserved in 18 of 25 patients with complete success, in 4 of 7 patients with partial success 
or procedural failure and in none of the 2 patients with undetermined procedural outcome. 
On univariable analysis LV function (p=0.01) and the number of induced VTs (p=0.02) were 
related to an unsuccessful procedure (table 2). 
The average procedure, fluoroscopy and RF time were respectively 221±73, 46±21 and 
22±16 minutes. There was no difference in procedure, fluoroscopy and RF time between 
Table 1. Baseline and hemodynamic characteristics
Characteristics  
Age (years) 48.6±13.2
Gender (male) 25 (74%)
Presentation
 Sustained monomorphic VT documented 27 (79%)
 Sustained monomorphic VT suspected 7 (21%)
  Resuscitated 1 (3%)
  Syncope 1 (3%)
  Palpitations and/or documented non-sustained VT 5 (15%)
Supraventricular Tachycardias 17 (50%)
 Atrial flutter 13 (38%)
 Atrial fibrillation 9 (27%)
 Atrioventricular nodal reentry tachycardia 1 (3%)
Medication at Admission
 Class-I anti-arrhythmic drug 1 (3%)
 Class-III anti-arrhythmic drug 11 (32%)
  Amiodarone 5 (15%)
 Beta-Blocker 16 (47%)
 Calcium-Antagonist 1 (3%)
Echocardiography 32 (94%)
 TAPSE ≥14 mm (applied in 28/32 pts) 22 (79%)
 Right Ventricular Function 
  Good 9 (28%)
  Mildly Reduced 13 (41%)
  Moderately Reduced 6 (19%)
  Severely Reduced 4 (13%)
 Left Ventricular Function 
  Good 13 (41%)
  Mildly Reduced 13 (41%)
  Moderately Reduced 4 (13%)
  Severely Reduced 2 (6%)
MRI 11 (32%)
 RVEF≥40% 9 (82%)
 LVEF≥40% 11 (100%)
Preserved cardiac function 22 (65%)
PVR, pulmonary valve replacement; TAPSE, tricuspid annular plane systolic excursion; and VT, ventricular tachycardia. 
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patients with and without complete procedural success. Two patients had procedural 
complications. One patient with poor cardiac function required ICU admission after 
cardioversion of a hypotensive VT followed by low cardiac output. He fully recovered 
the following day. One patient had femoral access site bleeding requiring transfusion. There 
was no procedural related mortality.
Follow-up 
Twenty-seven (79%) patients were discharged with an ICD, table 3. Five of the 25 patients 
with complete success were discharged with antiarrhythmic drugs (amiodarone 1, sotalol 
4) because of supraventricular arrhythmias (n=4) and/or presentation with an electrical 
storm (n=2). Fifteen of the 18 patients with complete procedural success and preserved 
cardiac function were discharged without any AAD. Four of the 9 patients without complete 
Figure 2. Schematic overview and prevalence of the six identified anatomical isthmuses. A-C previously 
reported anatomical isthmuses.9 Additional isthmuses are illustrated (D, patient 29 (supplement), 
complex TGA; E, patient 32 (supplement), VSD, bicuspid aortic valve and baso-inferolateral scar). 
The number of critical VT isthmus (n=59) mapped to anatomical isthmuses is provided (brackets). 





procedural success received AAD (Amiodarone 2, Sotalol 2). During long-term follow-up 
of 46±28 months all patients with complete procedural success remained free of SMVT 
recurrence (figure 3). None of the 18 patients with complete success and preserved cardiac 
function experienced any sustained VA. One patient with complete procedural success 
but poor cardiac function received an ICD shock for VF. Spontaneous SMVT recurred in 4/9 
patients without complete procedural success and were terminated by the ICD. In all four 
patients, the difference between targeted and spontaneous VTCL was <30msec, suggesting 
recurrence of the same VT. Four patients died during follow-up, two of heart failure (no 
complete success), one gastrointestinal carcinoma and one of leukemia 
No complete procedural success and decreased LV function (p=0.01) were predictors 
for SMVT occurrence during follow-up (table 4). No complete procedural success (p=0.02), 
Table 2. Univariate predictors of no complete procedural success 
Univariate Variables No Complete Success
Odds Ratio (95% CI) p
Male 1.36 (0.23-8.22) 0.74
Age, per 10 year↑ 1.56 (0.83-2.94) 0.17
Age of repair, per 5 year↑ 1.25 (0.86-1.82) 0.24
Pulmonary valve replacement (yes) 1.58 (0.30-8.35) 0.59
LV function, per category↓ 7.10 (1.62-31.09) 0.01
RV function, per category↓ 1.24 (0.58-2.66) 0.58
Impaired cardiac function (yes) 3.21 (0.66-15.58) 0.15
Number of induced VTs 2.33 (1.12-4.86) 0.02
Mean CL of induced VTs, per 10 ms↑ 1.04 (0.93-1.16) 0.47
Cl, cycle length; LV, left ventricular; RV, right ventricular; VT, ventricular tachycardia.





Follow-up (months) 46±22 46±31 0.994
SMVT 4 (44%) 0 (0%) <0.001
VF 0 (0%) 1 (4%) 0.527
ICD 9 (100%) 18 (72%) 0.205
 Appropriate Therapy 4 (44%) 1 (6%) 0.042
  ATP 4 (44%) 0 (0%) 0.007
  Shock 2 (22%) 1 (6%) 0.350
 Inappropriate Shock 1 (11%) 5 (28%) 0.277
Mortality, all-cause 3 (33%) 1 (4%) 0.025
Mortality, cardiac 2 (22%) 0 (0%) 0.010
SMVT, sustained monomorphic ventricular tachycardia; VF, ventricular fibrillation.
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impaired LV function (p=0.01) and impaired cardiac function (p=0.05) were predictors for 
any VA occurrence (table 4). 
ICD related complications
Ten of the 27 ICD recipients experienced ≥1 ICD related complications during follow-up: 
lead fracture (n=1), ICD extraction due to infection (n=4) and ≥1inappropriate shocks (n=6) 
in response to supraventricular tachycardia (n=5) or RV lead over-sensing (n=1). Twelve 
of the 18 patients with complete procedural success and preserved cardiac function were 
discharged with an ICD and 5 (42%) of them experienced ICD related complications.
Figure 3. Occurrence of sustained monomorphic ventricular tachycardia (SMVT) during 
long-term follow-up 
Table 4. Univariate predictors for SMVT/VA occurrence during follow-up 
Univariate Variables
Any SMVT during FU Any VA during FU
Hazard Ratio (95% CI) p Hazard Ratio (95% CI) p
Male 0.35 (0.05-2.53) 0.30 0.54 (0.09-3.23) 0.50
Age, per 10 year↑ 2.38 (0.97-5.83) 0.06 1.84 (0.88-3.84) 0.11
Age of repair, per 5 year↑ 1.25 (0.74-2.11) 0.40 1.25 (0.74-2.11) 0.40
Pulmonary valve replacement (yes) 2.94 (0.41-20.98) 0.28 1.85 (0.31-11.14) 0.50
LV function, per category↓ 5.48 (1.45-20.69) 0.01 4.63 (1.60-13.43) 0.01
RV function, per category↓ 1.26 (0.48-3.31) 0.64 1.40 (0.61-3.22) 0.43
Impaired cardiac function (yes) 7.02 (0.73-67.90) 0.09 9.43 (1.05-84.98) 0.05
Number of induced VTs 1.42 (0.69-2.93) 0.34 1.31 (0.70-2.45) 0.40
Mean CL of induced VTs, per 10 ms↑ 1.03 (0.93-1.14) 0.59 1.04 (0.95-1.14) 0.36
No complete procedural success       13.35 (1.43-124.32) 0.02






To the best of our knowledge this is the largest series of VT ablation in patients with rCHD 
(all available data provided in supplemental table B). Furthermore, ablation was performed 
with the same systematic approach irrespective of the type of malformation and type 
of repair, targeting anatomical isthmuses. We found that transection of VT associated 
anatomical isthmuses by RFCA is feasible in 74% of patients and is highly effective to 
prevent VT recurrence during long-term follow-up. Of importance, in patients with 
complete procedural success and preserved cardiac function our findings suggest that this 
substrate based approach may be considered curative. None of these patients experienced 
arrhythmias during follow-up ranging from 3 to 128 months, but 42% experienced 
ICD associated complications. Only 3 were on antiarrhythmic drugs mainly due to 
supraventricular arrhythmias. 
The substrate for fast VT and SCD
Ventricular arrhythmias are an important cause of morbidity and mortality in CHD. In rTOF, 
monomorphic VT is the most frequently documented VA accounting for >80% of all VA 
episodes.6 The cumulative incidence of sustained VT and SD has been estimated to be 11.9% 
and 8.3%, respectively at 35 years after repair of TOF and it has been suggested that SD 
is often due to sustained VT.16 Of interest, mapping studies performed for both tolerated 
and hemodynamically untolerated VTs demonstrated that the majority of monomorphic VTs 
are due to macro re-entry with critical isthmuses located within anatomical isthmuses.8, 9 
When rapid, these VTs may be fatal even in the presence of a preserved cardiac function. 
The median VT rate in the current series was 203bpm and for rTOF patients 211bpm, which 
is similar to the VT rate reported in a recent series of TOF patients receiving ICDs.6 Moderate 
to severe systemic and subpulmonary dysfunction defined as EF<40% has been associated 
with sudden arrhythmic death in patients with CHD.17 However, two thirds of patients 
with CHD that died suddenly had preserved systemic and subpulmonary function, which 
is comparable to our population.17, 18 These findings support the concern that untreated, 
fast monomorphic VTs is an important cause of SCD when it occurs in CHD with preserved 
ventricular function. 
Outcome of ablation
In our series the substrate of all clinical or presumed clinical VTs was located within an 
anatomical isthmus and we failed to identify an anatomic isthmus for only 2/61 induced VTs. 
Repaired TOF constitute the largest subgroup in whom VT ablation is reported and comprised 
82% of patients in the current series. However, SMVT related to anatomical isthmuses also 
occurs in other malformations repaired with surgical scars and patch material, and these can 
be effectively treated by the same systematic approach. All VT related anatomical isthmuses 
could be successfully transected in 25 patients resulting in non-inducibility of any VT. None 
of these 25 patients experienced any monomorphic VT during a mean follow-up of 46 
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months. This absence of VT is remarkable compared to the 9.8% annual rate of appropriate 
ICD shocks in TOF patients who receive an ICD after experiencing VA.6 This finding supports 
the hypothesis that the substrate for the fast and monomorphic VTs is indeed confined to 
the anatomical isthmuses and can be successfully abolished by blocking these isthmuses. 
The suggested ablation approach may be comparable to isthmus ablation for cavotricuspid 
isthmus dependent flutter, which also has high acute and long-term success rates. Our 
findings suggest that isthmus ablation with complete procedural success may be considered 
curative in patients in whom other ventricular arrhythmia mechanisms are unlikely, and who 
have preserved cardiac function. These patients had no arrhythmia recurrences and low 
all-cause and cardiac mortality. 
Procedural failure 
Procedure failure seemed to have an anatomic basis in 6/9 patients. In three patients 
the anatomical isthmus (isthmus 1 in 1, isthmus 3 in 2 patients) could not be transected, 
most likely due to hypertrophied myocardium, despite the use of steerable sheaths and 
irrigated catheters. In two patients an implanted pulmonary homograft, covering parts of 
the infundibular septum prevented transection of anatomical isthmus 3. In one patient RFCA 
was withheld to avoid heart block (isthmus 4). The cumulative incidence of VT recurrence 
after procedure failure was 100%. Therefore surgical transection of anatomical isthmuses 
seems a reasonable consideration in those patients that undergo re-operation for pulmonary 
valve regurgitation and in whom intraoperative ablation can be performed safely. After 
a failed endocardial approach of a hypertrophied free wall isthmus an epicardial approach 
may be considered for refractory VTs. However, epicardial access is likely to be hampered 
by adhesions after prior surgery and should therefore be performed in co-operation with 
a surgeon. 
ICD therapy
The favourable long-term results in patients with procedural success and preserved cardiac 
function suggest that selected patients may perhaps not benefit from ICD therapy. ICD related 
complications occurred in 42%, which is in line with prior reports.6, 7 However, larger studies 
with longer follow-up are required to exclude that other VA mechanisms may be operative 
in patients with successful ablation of anatomical isthmus related VT and preserved cardiac 
function. In patients with impaired LV function ICD implantation is important, as these 
patients have a significant risk of arrhythmia recurrences.6 As in other cardiomyopathies 
with depressed cardiac function, heart failure related VA mechanisms may be operative. In 
our series one patient with procedural success for SMVT and depressed cardiac function 
received an ICD shock for VF. Our results support the current guidelines stating that ICD 
implantation is not recommended in patients with CHD and spontaneous VT, when the VT 
can be successfully treated with surgery or RFCA, provided, however, that cardiac function is 
preserved.10 Patients discharged without ICD should undergo regular assessment of cardiac 





The present study is limited by design and number of patients. Therefore, it is not possible 
to adjust for confounding in the prediction of acute and long-term outcome. In addition, 
the results of a case series from two high volume centres may not be translated to other less 
experienced groups. Testing for bidirectional block of the anatomical isthmus has evolved 
over time and only in the latter patients pacing manoeuvres were performed. However, 
no-capture along the line and change of activation sequence as procedural outcome were 
associated with no VT recurrence and may already be therefore a sufficient endpoint for 
a linear lesion. 
CONCLUSION 
In patients with rCHD with preserved left and right ventricular function and anatomical 
isthmus dependent reentry, VT isthmus ablation can be curative. 
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 · Ventricular arrhythmias (VA) are an important cause of late morbidity and mortality 
in the growing population of adults with repaired congenital heart disease (rCHD).
 · The majority of these VA are fast, monomorphic and thereby life-threatening 
ventricular tachycardia (VT).
 ·  Small studies have demonstrated that the VT substrate in rCHD often includes 
anatomical isthmuses that can be transected by radiofrequency catheter ablation 
(RFCA) with favorable outcome. 
What the study adds
 · In a large group of rCHD patients, transection of VT associated anatomical isthmuses 
by RFCA is feasible in 74% of the patients and is highly effective to prevent VT 
recurrence during long-term follow-up. 
 · In selected patients with rCHD, with preserved left and right ventricular function, 
and anatomical isthmus dependent reentry VT in whom other VA mechanisms are 
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Radiofrequency catheter ablation (RFCA) of ventricular tachycardia (VT) in repaired 
Tetralogy of Fallot (rTOF) focuses on isthmuses in the right ventricle but may be hampered 
by hypertrophied myocardium or prosthetic material. These patients may benefit from 
ablation at the left side of the ventricular septum. 
Methods and Results
Records from 28 consecutive rTOF patients from two centres, who underwent VT ablation, 
were reviewed. Ablation targeted anatomical isthmuses containing VT reentry circuits 
identified by 3D substrate, pace and/or entrainment mapping. A left-sided approach was 
considered beneficial if (1) right-sided RFCA failed, (2) part of the circuit was mapped to 
the left side and (3) left-sided RFCA resulted in isthmus transection and prevention of 
VT induction. In 4/28 patients (52±13 years, 75% male), inducible for 1.5 (quartiles, 1.0 – 
2.0) VTs (335±58 msec), left-sided RFCA was performed. In 3 patients RFCA at aortic sites 
terminated VT related to a septal isthmus and prevented re-induction. In 1 patient, with 
prior biventricular ICD, diastolic activity was recorded at the left side of the septum in 
proximity to the His-bundle. RFCA prevented VT re-induction with anticipated complete 
AV-block. The left-sided approach resulted in complete procedural success (transection of 
anatomical isthmus and non-inducibility) and freedom of VT recurrence during follow-up 
(20±15 months) in all patients. Right-sided RFCA failure was likely due to septal hypertrophy 
in 2, the overlying pulmonary homograft in 1 and overlying VSD patch in 1. 
Conclusion
Left-sided RFCA for VTs dependent on septal anatomical isthmuses improves ablation 
outcome in rTOF. 




The population of adults with repaired Tetralogy of Fallot (rTOF) is increasing, as improved 
surgical techniques are extending survival.1 Ventricular arrhythmias (VA) are an important 
reason for late morbidity and mortality.1, 2 The majority of VA in rTOF are monomorphic VTs.3 
The potential re-entry paths causing these VTs are now well described and contain anatomical 
isthmuses bordered by unexcitable tissue from the tricuspid or pulmonic valve annuli, 
surgical scars and patch material.4 Radiofrequency catheter ablation (RFCA) of the anatomical 
isthmus causing VT can be highly effective for preventing recurrent VT.4 However, achieving 
conduction block across an isthmus can be difficult due to the hypertrophic myocardium or 
protection of portions of the isthmus under prosthetic patches or valve homografts. This is 
particularly true for isthmuses in the outlet septum where the VSD patch is typically located. 
The aim of this study was to assess the feasibility and utility of ablation from the left ventricle 
or aorta when ablation from the right ventricle fails. We demonstrate for the first time, to our 
knowledge, successful ablation of VTs involving the outflow septum using a combined right 
and left ventricular/aortic root ablation approach.
METHODS
Population 
The procedural data of twenty-eight consecutive patients with rTOF, who underwent RFCA 
of VT in two centres between 2001 and 2013, were reviewed. Patients in whom a left-sided 
approach was performed were included in the current series. A left-sided approach was 
considered beneficial if (1) RFCA from the RV failed to prevent VT induction and/or isthmus 
transection and/or VT recurrence, (2) parts of the VT re-entry circuit isthmus were mapped to 
the left ventricle (LV) or aortic root and (3) RFCA applied from the left side resulted in isthmus 
transection and prevented VT induction. The medical records of the patients were reviewed 
for the surgical history, documentation of spontaneous VT, previous VT ablation and failed 
drugs. Imaging studies were reviewed for left and right ventricular function at the time of 
referral. The RV systolic function was semi-quantitatively analysed.5, 6 The LV ejection fraction 
was derived by Simpson’s method. All patients were treated according to the routine clinical 
protocol and provided informed consent.
Procedure 
The systematic approach for ablation of macro-reentry VT in rTOF has been previously 
described in detail.4 Briefly, the (re-)induction protocol existed of two or three drive cycle 
lengths (600, 500 and 400 msec) with up to three extra stimuli, burst pacing and isoproterenol 
from ≥2 RV sites (apex and RV outflow tract (RVOT)). A RV bipolar electroanatomical 
voltage map (EAM) was created using a 3D mapping system (Carto XP/3, Thermocool 
catheter, Biosense Webster, Inc; Diamond Bar, Calif ). At low voltage sites (bipolar recording 
<1.5mV), high output pacing (10mA at 2-ms pulse width) was performed to identify areas 




previous RV incisions), the pulmonary valve (PV) and the tricuspid annulus (TA) were defined 
as boundaries of the four previously described anatomical isthmuses in rTOF (for details 
see figure 1). Two of these anatomical isthmuses (isthmus 3 and 4) involve the septum. 
The relationship between the critical reentry circuit isthmus of each VT and the anatomical 
isthmuses was confirmed by concealed entrainment, diastolic activity with VT termination 
during RF delivery for tolerated VT and/or pace mapping (PM) at sites where QRS morphology 
matched VT morphology (≥11/12).8 The anatomical isthmus containing the critical VT reentry 
site was transected with RF current using an open saline-irrigated catheter (power 35-50 W, 
maximum temperature 45°C) until high output (at least 10 mA, 2 ms pulse width) pacing fails 
to capture along the ablation line. Block was further supported by the presence of double 
potentials and/or a change in activation sequence during SR or RV-pacing after ablation. 
More recently differential pacing was performed to confirm bidirectional conduction block.9 
After transection of the anatomical isthmus programmed stimulation was repeated. 
Figure 1. The previously described four anatomical isthmuses for VT in rTOF.4 Anatomical isthmus 
1 is located between the TA and a RV incision/RVOT patch (panel A, B) and anatomical isthmus 2 is 
located between a RV incision and PV (panel B). Anatomical isthmus 3, located between the PV and 
VSD-patch and anatomical isthmus 4, located between the VSD-patch and TA (panel C) are bordering 
on the septum. Ccw indicates counter clockwise; cw, clockwise; PV, pulmonary valve; rTOF, repaired 
Tetralogy of Fallot; RV, right ventricle; RVOT, RV outflow tract; TA, tricuspid annulus; VSD, ventricular 
septal defect; VT, ventricular tachycardia. 




If VT could not be abolished from the RV and the anatomical isthmus containing reentry circuit 
sites was in or bordering on the septum, the aorta and LV were mapped using a retrograde 
approach. The described criteria were applied to confirm that parts of the reentry circuit 
were located within the same anatomical isthmus but approachable from the left ventricle or 
aorta. Before RF delivery at aortic sites coronary angiography or aortography was performed 
to identify the coronary ostia. In the aorta power was limited to a maximal of 35 Watts 
(figure 2). After RFCA, the induction protocol was repeated.
Figure 2. Mapping catheter position on fluoroscopy (case 1). Position of the mapping catheter in the RV 
during angiography of the aorta in LAO (panel A) and RAO (panel B) view. Position of the mapping 
catheter in the left coronary cusp of the aorta during VT termination in LAO (panel C) and RAO view 





In patients without an ICD prior to ablation, an ICD was recommended if indicated according 
to current guidelines. VA recurrence was defined as documented spontaneous sustained VA 
and/or symptoms highly suspicious for sustained VA. For patients that were not followed at 
the two institutes, records of the clinical and device follow-ups including the most recent 
were obtained.
Anatomy 
In order to gain more insights in the anatomical substrate that may require left-sided RFCA 
in rTOF, the Leiden collection of malformed hearts was reviewed for rTOF post-mortem 
specimens. Study of this collection was undertaken in accordance with the local ethics 
committee and the Dutch regulation for the proper use of human tissue for medical research 
purposes. Two post-mortem specimens were selected to illustrate (1) the relation between 
the patch material and the adjacent myocardium and (2) the specific anatomical location 
and morphology of the infundibular septum. 
RESULTS
In 11 of the 28 (39%) consecutive patients with rTOF right-sided RFCA failed to abolish all 
inducible VTs. In 8 of these 11 patients the VT was mapped to a septal anatomical isthmus 
(isthmus 3 in 7 pts, isthmus 4 in 1 pt). In four patients a left-sided approach was not taken 
due to procedural considerations (length of the procedure, poor condition of the patient, 
inability to re-cross the aortic valve due to position of the aortic root and mild aortic valve 
stenosis). The presumed reasons for failure of right-sided ablation in these four patients were 
hypertrophy of the outlet septum in two and a pulmonary homograft in two. In the remaining 
four patients left-sided mapping and RFCA were performed. These four patients (52±13 
years (mean±sd), 75% male) were inducible for a median of 1.5 VT (quartiles, 1.0 – 2.0) with 
a mean VT cycle length of 335±58 msec. Table 1 summarises the baseline characteristics. 
Case 1
A 58 year old male had undergone total correction (infundibular resection, transannular 
patch, patch closure of a perimembranous VSD) at the age of 13 and presented with recurrent, 
symptomatic, self-terminating broad-complex tachycardias. Echocardiography and MRI 
revealed severe pulmonary valve regurgitation requiring pulmonary valve replacement 
(PVR). Before surgery programmed electrical stimulation (PES) and RV EAM were performed. 
Two fast VTs (cycle lengths 250ms, figure 3) were inducible and substrate mapping identified 
two anatomical isthmuses: isthmus 1 between the transannular patch and the tricuspid 
annulus (TA) and isthmus 3 between the pulmonary valve (PV) and the VSD-patch. Both 
VTs could be mapped to anatomical isthmus 3 with a clockwise activation during VT1 (QR 
in V1) and counterclockwise activation during VT2 (late transition in precordial lead V5). As 
the patient was scheduled for re-surgery, PVR was combined with intraoperative cryoablation 
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Table 1. Patient characteristics and procedural data. 
Patient Characteristics Patient 1 Patient 2 Patient 3 Patient 4
Age (years) 58 67 45 37
Gender Male Female Male Male
Prior Shunt No No Yes No
Age of Repair (years) 13 15 4 3
Type of VSD Peri-M Peri-M Musc Peri-M
Reoperation PVR VSD closure VSD closure None
Failed drugs None Sotalol Sotalol Sotalol 
Mexiletine
LV ejection fraction 54% 43% 39% 61%
RV function Moderately Red Severely Red Moderately Red Mildly Red
VT induced (n) 2 1 2 1
Septal isthmus dependent (n) 2 1 1 1
VTCL of induced VT (ms) 245+255 370 370+380 345
Presumed reason P Homograft Hypertrophy VSD-patch Hypertrophy
right-sided failure
Drugs at discharge None Sotalol Sotalol Nadolol
LV = left ventricular; Peri-M = perimembranous; P homograft = pulmonary homograft; PVR = pulmonary valve 
replacement; Red = reduced; RV = right ventricular; VSD = ventricular septal defect; VT = ventricular tachycardia; 
VTCL = VT cycle length. 
of isthmus 3. At the postoperatively performed EP study VT1 was again inducible and an 
ICD was implanted before discharge. Subsequently he had multiple VT episodes terminated 
by ATP and was intolerant of sotalol. Six months after surgery VT ablation was attempted. 
Although pacing at isthmus site 3 did not capture, the activation map during sinus rhythm 
was consistent with continuous conduction through isthmus 3. During VT 1 diastolic activity 
was recorded at isthmus 3 but RFCA at that region did not terminate VT. These findings 
suggested that the pulmonary homograft was covering the infundibular septum (figure 4) 
mimicking scar between the prior pulmonary annulus and the TA. Pacing at the opposite 
site within the left coronary cusp (LCC, figure 2) captured and resulted in a 12/12 pace-map. 
During VT mid-diastolic activity was recorded at this site, and RF application terminated VT 
within 18 seconds and prevented VT re-induction. During 21 months of follow-up the patient 
had no VT recurrence.
Case 2
A 66 year old female underwent primary repair of TOF at the age of 15 years with resection of 
severely hypertrophied infundibular muscle, commissurotomy of the PV, partial patch closure 
of a large perimembranous VSD and suture of a large longitudinal RV incision. Thirteen years 
later complete closure of the VSD was performed. She subsequently developed recurrent, 
symptomatic VT terminated by antitachycardia pacing (ATP). During EP study the presumed 




two anatomical isthmuses bordered by EUS; isthmus 1 between a longitudinal EUS area 
(consistent with the previous anterior RV incision) and the TA and isthmus 3 bordered by an 
area of EUS in continuity with the TA consistent with the VSD patch and the PV. A good PM 
for the presumed clinical VT was obtained at isthmus 3. Activation mapping was consistent 
with counterclockwise propagation (late transition in precordial lead V6) through isthmus 
3. Entrainment mapping at this site revealed a central isthmus site and RF slowed and 
terminated the VT within 10 seconds, rendering the VT non-inducible. A linear RF lesion was 
performed to connect the areas of EUS. However, the activation sequence during pacing 
proximal to the line was still consistent with conduction through the isthmus.
After 3 months VT recurred. At repeat study the same VT was inducible. Although double 
potentials could be recorded along isthmus 3 during sinus rhythm, differential pacing was 
consistent with persistent slow conduction through the isthmus. During VT diastolic activity 
could be recorded within isthmus 3 and RF delivery resulted in delay and late termination of 
VT, but the VT remained inducible. Mapping at the left side of the region from within the right 
coronary cusp (RCC) revealed diastolic activity (30 msec before the earliest activation in 
the RVOT) and entrainment consistent with an isthmus site (figure 5). RF ablation at that 
site terminated VT within 5 seconds and prevented VT re-induction. Differential pacing 
Figure 3. 12 lead ECGs (sweep speed 25mm/s and 100mm/s) of the induced septal VTs in all four cases. 
In patient one, two and four, the critical reentry site was located at anatomical isthmus 3 (isthmus 
between VSD-patch and PV). VT1 in patient one and VT1 in patient four demonstrated a clockwise 
(cw) activation of isthmus 3, please note the QR in lead V1. On the contrary, VT2 in patient one and VT1 
in patient two demonstrated a counter clockwise (ccw) activation of isthmus 3, please note the late 
transition in precordial leads. In patient three, the critical reentry site of VT2 was located at anatomical 
isthmus 4 (isthmus between VSD-patch and TA) and the VT demonstrated cw rotation through isthmus 
4. PV, pulmonary valve; TA, tricuspid annulus; VSD, ventricular septal defect; VT, ventricular tachycardia. 
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performed from the RVOT was consistent with conduction block. The patient continued with 
a low dose of Sotalol and remained free of VT during 15 months of follow-up.
Case 3 
A 45 year old male with rTOF (operation reports not available) who had undergone CRT-D 
implantation for VTs and progressive heart failure was referred for VT ablation after prior 
ablation attempts in other centers had failed. Two VTs were inducible (VT1, cycle length 
370ms and VT2, cycle length 380ms). RV EAM revealed a small low voltage area in the RV free 
wall perhaps consistent with a prior incision and a second low voltage area at the septum 
bordered by the TA and an area of EUS in continuity with the PV most likely consistent with 
a VSD patch. Hence, two anatomical isthmuses were identified: isthmus 1 between the TA 
and the small free wall scar and isthmus 4 between the VSD-patch and the TA. VT1 could 
Figure 4. Intraoperative view of pulmonary valve replacement by pulmonary homograft in a patient 
with repaired Tetralogy of Fallot. Left panel a cranial (top) to caudal view, right panel a caudal to 
cranial view. The anterior suture line is marked with the dashed line in both pictures. At both panels 
the pulmonary homograft is held by the forceps. The pulmonary homograft is already posteriorly sutured 
to the VSD-patch (marked with *). After complete implantation of the homograft, important parts of 
the RVOT endocardium and in particular the infundibular septum are covered by the homograft. * = 
VSD-patch; RA = right atrium; RV = right ventricle; RVOT = right ventricular outflow tract; TA = tricuspid 




Figure 5. Panel A: Electroanatomical activation map of the clinical VT (activation time color coded 
according to bar) in left posterior and right lateral views. Earliest RVOT activation was recorded at 
the anatomical isthmus between the PV and VSD-patch. Diastolic activity preceding RVOT activation by 
30 msec could be recorded from the aortic root. Panel B: From the aortic site VT could be entrained with 
concealed fusion (PPI=VTCL=348ms). RF at this side terminated VT within 5 seconds. MAP d = bipolar 
recording of the distal mapping catheter; PPI = post pacing interval; PV = pulmonary valve; RVa = right 
ventricular apex; RVOT = right ventricular outflow tract; VSD = ventricular septal defect; VT = ventricular 
tachycardia; VTCL = VT cycle length.
be mapped to isthmus 1 and was ablated by connecting the presumed prior incision with 
the TA.
During VT2 (figure 3), presystolic activity was recorded at the lower edge of the presumed 
VSD patch with clockwise propagation through isthmus 4. However, the appearance of 
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the electrogram was consistent with a far-field signal and RF delivery did not terminate VT. 
At the adjacent LV site a good PM for VT2 was obtained, diastolic activity was present during 
VT, and a His-bundle electrogram was present in sinus rhythm. RF ablation was performed 
and resulted, as anticipated, in complete heart block. Thereafter, VT was no longer inducible. 
Sotalol was continued. He remained free of VT during 40 months of follow-up. He received 
one ICD shock for ventricular fibrillation after 15 months.
Case 4 
A 36 year old male with rTOF (operation report not available) who had undergone ICD 
implantation and a previous VT-ablation in another center presented with an electrical 
storm and multiple ICD shocks. The presumed clinical VT (cycle length 345ms) was induced 
(figure 3). RV EAM identified isthmus 1 between EUS in the anterior RVOT in continuity with 
the PV and isthmus 3 bordered by EUS in continuity with the TA (VSD patch) and the PV. 
Entrainment at the ventriculo-infundibular fold was compatible with a VT entrance site and 
clockwise activation (QR in V1) of isthmus 3. However, RF at this site did not terminate VT. 
At the opposite side in the aorta, between the RCC and the NCC, a late potential (220 msec 
after QRS offset) was recorded during SR (figure 6). During VT mid diastolic activity was 
present and entrainment was consistent with an central isthmus site. A single RF application 
terminated VT within 10 seconds and prevented subsequent VT induction. To minimize 
procedural risks, no additional RF applications were performed in the aortic root. 
VT recurred after 1 month and a repeat procedure was performed. The previous 
recorded VT could be induced. Activation mapping confirmed a reentry circuit entrance at 
the ventriculo-infundibular fold and an exit at the RCC region. A line of RF lesions was placed 
across isthmus 3 from the RV, the LVOT and the area between the LCC and RCC, abolishing 
inducible VT. The patient was discharged on nadolol and remained free of VT during 3 
months of follow-up.
DISCUSSION
A right-sided RFCA approach for VT in rTOF targeting anatomical isthmuses failed to abolish 
inducible VT in 39% of our rTOF patients. Of importance, the majority (8/11) of these patients 
had a proven VT substrate involving anatomical isthmuses located at the infundibular 
septum. In all 4 patients in whom a left-sided approach was performed after right-sided 
ablation failure diastolic activity and/or concealed entrainment could be recorded either 
from the aortic root in muscular continuity and opposite to isthmus 3 (figure 7) or in the LVOT 
at the left sided inferior border of the VSD patch consistent with isthmus 4. RFCA at these 
sites terminated VT and/or prevented VT re-induction. The left-sided approach resulted in 
complete elimination of inducible VT and prevention of VT recurrence during follow-up 
(20±15 months) without procedure related complications in all cases, although one patient 
required two left-sided procedures. Based on the operation records, intraoperative and 




hypertrophic myocardium (case 2 and 4), overlying parts of a homograft (case 1) or overlying 
VSD patch material (case 3).
Anatomical considerations
The outlet septum as important feature of TOF and substrate for VA
TOF is characterized by a (sub)pulmonary stenosis, overriding aorta, VSD and RV 
hypertrophy.10 Probably the most important pathologic feature of TOF is anterior 
displacement of the infundibular septum which results in a subaortic VSD, subpulmonary 
stenosis and dextroposition of the aorta overriding the ventricular septum. The infundibular 
septum, i.e. outlet septum, is located between the ventriculo-infundibular fold and 
the trabeculo septomarginalis and cannot be recognized as a separate structure in 
the normal heart.10, 11 However in TOF, the infundibular septum can be recognized due to 
its anterior displacement located between the narrowed pulmonary outflow tract and 
the aortic valve (figure 7 and 8).10, 11 The outlet septum in TOF is therefore approachable 
from the right side (RV and RVOT) and left side (LV, LVOT and aortic root) (figure 7). 
The thickness of the infundibular septum in TOF can vary from thin fibrous tissue to severely 
hypertrophied myocardium.10, 11 
Figure 6. Electroanatomical voltage map (voltage color coded according to bar) of the right ventricle 
(RV) and coronary cusps in a modified right posterior view. After failed ablation in RV, the aortic root 
was mapped (cusp anatomy visualized by intracardiac echo using CartoSound® technology). During 
SR a late potential could be recorded between the NCC and RCC and during VT entrainment was 
consistent with an isthmus site. A single RF application terminated VT within 10 seconds. LCA = left 
coronary artery; L/N/RCC = left/non/right coronary cusp; PV= pulmonary valve; TV = tricuspid valve. 
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Histological study of the crista supraventricularis (i.e. outlet septum) in TOF have 
demonstrated that (ultra)structural abnormalities (interstitial fibrosis in 65% of the cases) 
are already present before surgical correction.12 These (ultra)structural abnormalities and 
the surgical correction cause myocardial scarring that may provide the substrate for slow 
conduction and may explain the importance of the infundibular septum for reentry VT. 
Figure 7. Right ventricular view of a post-mortem specimen with unrepaired Tetralogy of Fallot (4 years 
old). Panel A provides an overview. Panel B, C and D show the relation between the aorta and outlet 
septum (*) in detail. The catheter at panel C is positioned in the left coronary cusp. The catheter at panel 
D is positioned at the pulmonary side of the outlet septum. Please note the spatial relationship between 
the outlet septum and the sinus of the aorta. Ao = Aorta; LV = left ventricle; RVOT = pulmonary outflow 




Prosthetic material and ablation failure
During the primary repair, the VSD is closed with a patch and the (sub)pulmonary stenosis 
is relieved by resection of the hypertrophied infundibulum and/or a (transannular) patch 
with additional commisurotomy in some cases.13 After correction, the infundibular septum 
(i.e. the deviated outlet septum) can remain a hypertrophied, muscular structure (figure 8) 
bordered by PV and VSD (patch). To transect this anatomical isthmus (isthmus 3) ablation 
from both the right and left side may be required (figure 7 and 8). Pulmonary valve 
regurgitation, in particular after placement of a transannular patch may require PVR after 
initial total correction.14 Mosaic porcine, bovine pericardial, or homograft prostheses are 
used. Parts of the prostheses may extend towards the VSD patch thereby covering important 
parts of the infundibular septum (see figure 4). Accordingly the anatomical isthmus between 
the PV and the VSD may no longer be approachable for catheter ablation from the RV 
endocardium, and may therefore require a left-sided approach as demonstrated in case 1. 
Although not observed in our series the combination of graft material and hypertrophy may 
prevent effective RFCA after PVR even if a combined approach is used. Therefore we feel that 
preoperative EP study and intraoperative ablation of anatomical isthmuses related to VT is 
a reasonable consideration even in the absence of spontaneous VTs.
Potential complications
 In patients with a muscular VSD, which is present in approximately 20% of TOF patients, 
the posteroinferior border of the VSD is a muscular rim, which is often only a few millimeters 
broad. This anatomical isthmus (isthmus 4) is thus bordered by the VSD (patch) and the TA. 
Importantly, isthmus 4 can be partly covered by the VSD-patch, which is usually stitched 
some millimeters away from the edge of the rim to avoid damage to the His-bundle.13 
Therefore a left-sided approach may be required to transect parts of the isthmus covered by 
the patch. However, due to the proximity of the His-bundle there is a risk of total AV block 
with the consequent need for (bi)ventricular pacing, as illustrated in case 3. 
In this small series no other complications were observed. However, ablation in 
the aortic sinuses has a risk of coronary injury and the location of the coronary ostia should 
be visualized by angiography considering the potential for anatomical variation in TOF. RF 
ablation in the aortic root could also theoretically damage the aortic valve. 
CONCLUSION
Although VT in Tetralogy of Fallot is primarily right ventricular in origin, ablation from 
the left ventricle or aorta is required to interrupt some anatomical isthmuses bordering on 
the infundibular septum. Our limited series suggests that this approach may be of benefit 
to a significant number of patients in whom a right-sided approach fails. The proximity of 
the coronary arteries and the cardiac conduction system needs to be considered. 
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Figure 8. Right ventricular view of a post-mortem specimen with repaired Tetralogy of Fallot (24 years 
old). The correction consisted of infundibular resection and patch closure of a perimembranous VSD. 
Panel A1 and B1 provide an overview, panel A2 and B2 show the infundibulum and VSD in detail. 
The prior location of the VSD-patch (partly removed) is illustrated with the dashed circle in panel A2, 
the VSD-patch is removed in panel B1-2. A probe was inserted in the pulmonary artery (not visible) and 
advanced through the pulmonary valve (not visible) into the infundibulum (visible). The probe is located 
on the pulmonary side of the outlet septum, i.e. the isthmus between the VSD and pulmonary valve. 
B2, the outlet septum is marked by two dashed lines and perpendicular directed arrows, please note 
the thickness of the septum (9 mm) even after the correction. RV = right ventricular; TV = Tricuspid 





Ventricular arrhythmias are an important cause for late morbidity and mortality in a growing 
population of adults with repaired Tetralogy of Fallot. The majority of these ventricular 
arrhythmias are re-entrant ventricular tachycardias (VTs), which are related to anatomic 
isthmuses usually approached from the right ventricle. These VTs can be successfully 
treated with radiofrequency catheter ablation (RFCA) provided that the anatomic isthmus 
can be completely transected. In the present study performed in 28 consecutive repaired 
Tetralogy of Fallot patients, right-sided RFCA failed to abolish the VTs in 11 (39%) patients. 
Of importance, in 8 of 11 patients, the VT was mapped to a septal anatomic isthmus. In 4 of 8 
patients, an additional left-sided approach was performed, and in all 4, the anatomic isthmus 
could be successfully transected from the left, resulting in noninducibility and freedom of 
VT recurrence during follow-up. RFCA was performed from the aortic root in 3 patients 
and in 1 patient, with a biventricular implantable cardioverter-defibrillator, from the left 
side of the septum in proximity to the His-bundle, followed by anticipated atrioventricular 
block. Based on the demonstrated anatomic and intraoperative observations, right-sided 
RFCA failure was likely because of the septal hypertrophied myocardium, the overlying 
pulmonary homograft, and overlying ventricular septal defect patch. A left-sided ablation 
approach should be considered in repaired Tetralogy of Fallot patients in whom right-sided 
RFCA of a septal anatomic isthmus failed. Knowledge of the anatomy, the type of repair, and 
reoperations are helpful to plan the procedure and to anticipate potential complications.
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QRS prolongation has been associated with ventricular tachycardia (VT) in repaired Tetralogy 
of Fallot (rTOF).
Objectives
To evaluate the influence of slow conducting anatomical isthmuses (SCAI) as dominant VT 
substrate on QRS duration. 
Methods
Seventy-eight rTOF patients (37±15 years, 52 male, QRS 153±29ms, 67 RBBB) underwent 
programmed stimulation and electroanatomical activation mapping during sinus rhythm. 
RV surface, RV activation pattern, RV activation time (RVAT), conduction velocity (CV) at 
anatomical isthmuses (AI) and remote RV sites were determined.
Results
Twenty-four patients were inducible for VT (VT+); SCAI was present in 22/24 VT+ but only in 
2/54 patients without inducible VT (VT-). CV through AI was slower in VT+ (0.3 (0.3-0.4) vs. 0.7 
(0.6-0.9)m/s, p<0.01) but CV in the remote RV did not differ between groups. In non-RBBB, 
QRS duration was similar in VT+ (n=6) and VT- (n=5), but RV activation within SCAI exceeded 
QRS-offset in VT+ (37±20 vs. -5±9ms, p<0.01). In RBBB, both QRS duration and RVAT 
were longer in VT+ (n=18, 17/18 QRS>150ms) compared to VT- (n=49, 27/49 QRS>150ms) 
(173±22 vs. 156±20ms, p<0.01; 141±22 vs. 129±21ms, p=0.04). In VT+ patients, QRS 
prolongation >150ms (n=17) was due to SCAI or blocked isthmus in 15 (88%) and 1 (6%). 
In contrast, in VT- patients, QRS prolongation >150ms (n=27) was due to enlarged RV or 
blocked isthmus in 10(37%) and 8 (30%), but due to SCAI in only 1 (4%). After exclusion of 
a severely enlarged RV, a QRS duration >150ms was highly predictive for SCAI/blocked AI 
(OR 16.6 (95%CI, 3.3– 84, p<0.01).
Conclusions
A narrow QRS does not exclude VT-related SCAI. In the presence of a RBBB, SCAI further 
prolongs QRS duration. A QRS>150ms is highly suspicious for a SCAI or isthmus block 
distinguishable by electroanatomical mapping.




As a result of earlier repair and evolving surgical techniques, the majority of patients with 
repaired Tetralogy of Fallot (rTOF) survive to adulthood,1-3 but may remain at risk of sudden 
cardiac death (SCD) due to ventricular arrhythmias (VA).4, 5 Monomorphic ventricular 
tachycardia (VT) is the most common arrhythmia subtype affecting >14% of patients and 
account for >80% of appropriate ICD therapies.6, 7 Over the last decades, efforts have been 
made to non-invasively identify rTOF patients at risk for VT. Although no single risk factor has 
shown sufficient independent predictive value for the presence of an arrhythmic substrate 
in an individual patient, a prolonged QRS duration>180ms has consistently been associated 
with VT and SCD.8-10 In contemporary cohorts, a lower QRS cut-off value to identify a patient at 
risk has been suggested and attributed to advances in surgical approaches.11, 12 The modern 
transatrial-transpulmonary surgical approach with smaller transannular patches may not 
only prevent severe pulmonary valve regurgitation and right ventricular (RV) dilatation 
but also right bundle branch damage. Accordingly, contemporary rTOF patients may have 
less RV dilatation, different RV activation patterns and even a narrow postoperative QRS.13 
QRS prolongation was initially thought to be the combined effect of a surgical created right 
bundle branch block (RBBB) and progressive, RV dilatation with global conduction delay, 
the latter creating a substrate for VT.9 However, invasive electroanatomical mapping studies 
have demonstrated that the dominant substrate for VT are slow conducting anatomical 
isthmuses (SCAI) confined to the RV outflow tract (RVOT).14 We hypothesize that the interplay 
between a postoperative RBBB and conduction delay in SCAI determines the RV activation 
pattern and QRS prolongation. The objective of this study is to evaluate, with the use of 
invasive electroanatomical mapping, if QRS prolongation is due to localized conduction 
delay across SCAI, rather than due to global conduction delay.
METHODS
Patient selection 
The cohort consisted of 83 consecutive rTOF patients with either documented sustained 
VT, or considered at risk for VT and/or with indication for re-operation who underwent 
electrophysiological evaluation and RV electroanatomical mapping (EAM) between 2005 
and 2013 at Leiden University Medical Center (n=53) and Bordeaux University Hospital 
(n=30). Patients were considered at risk for VT if ≥1 of the following risk factors was present: 
syncope, non-sustained VT on Holter, QRS duration ≥180ms, late repair (≥5 years), at least 
moderately depressed RV or LV function or presence of a transannular-patch.9, 10, 15-19 The Dutch 
Central Committee on Human-related Research (CCMO) permits use of anonymous data 
without prior approval of an Institutional Review Board, if the data are obtained for patient 
care and if the data do not contain identifiers that could be traced back to the individual 






Patient records were reviewed for date and type of repair, device implantation, and 
documented VA. Non-paced 12-lead ECGs recorded at 25mm/sec were assessed for QRS 
duration and intraventricular conduction disturbances. In 53/83 patients, QRS duration was 
also measured using LEADS (supplemental methods 1).20 Holter recordings were reviewed 
for non-sustained VT. Right and left ventricular (LV) cardiac function was assessed by cardiac 
magnetic resonance imaging (CMR) and/or echocardiography. A mildly reduced or good RV 
function (RV ejection fraction >40%) with a tricuspid plane systolic excursion ≥14mm and 
a LV ejection fraction ≥40% were classified as preserved RV and LV function, respectively.21 
Cardiac volumes were determined by CMR and indexed for body surface area. RV end 
diastolic volume index (RVEDVi) ≥180ml/m² was considered severely enlarged.22
Electroanatomical mapping and electrophysiological evaluation
Programmed electrical stimulation (PES) was performed (supplemental methods 2). Sustained 
VT was defined as lasting ≥30 seconds or causing hemodynamic compromise requiring 
termination. A detailed 3D EAM of the RV was constructed during sinus rhythm (SR) using 
a non-fluoroscopic mapping system (Carto3 & CartoXP, Biosense Webster). The endocardial 
RV surface was measured using dedicated tools of the CARTO system. EAM RV surface was 
compared to CMR-derived volume. All mapping points were reviewed offline for correct 
annotation of the local activation time (LAT), defined as the sharp bipolar electrogram 
coinciding with the fast down-stroke of the unipolar electrogram. All activation maps were 
displayed as isochronal maps and as propagation maps (online videos) to determine RV 
activation pattern. The site(s) of earliest and latest RV activation were identified and the total 
RV activation time was calculated. Earliest onset and latest offset of the QRS-complex in any 
lead were annotated on CARTO to assess QRS duration. QRS duration, total RV activation 
time (RVAT), and intervals between onset of QRS and onset of RV activation, and between 
offset of QRS and offset of RV activation were measured using electronic calipers (sweep 
speed 200mm/s, figure 1). 
Anatomical isthmus characteristics and its relation to ventricular 
tachycardia 
The identification of anatomical isthmuses (AIs) in rTOF has been described in detail 
(supplemental methods 3).23 Isthmus 1 is located between the tricuspid annulus (TA) and 
the RVOT-patch/RV-incision; isthmus 2 between the RV-incision and the pulmonary valve 
(PV). Isthmus 3 and 4 are located at the infundibular septum, with isthmus 3 between 
PV and VSD-patch, and isthmus 4 between VSD-patch and TA.23 The electroanatomical 
characteristics of each identified AI were assessed. The fill threshold for EAM of the AI was 
set at ≤10 mm and care was taken to delineate the length of the isthmus by recording 
the first normal voltage electrograms at isthmus entrance and exit sites.14 Isthmus length is 
the distance between entrance and exit sites and the conduction time through the isthmus 
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Figure 1. Activation time measurements. Panel A: Schematic of QRS and RV activation time 
measurements. Panel B: RV electroanatomical map (EAM) of a patient (RBBB, QRS 132ms) in three views 
displayed as bipolar voltage map (left) and activation map (right). Voltage and local activation time 
(LAT) are color coded. Three anatomical isthmuses are shown: isthmus 1 (between tricuspid annulus 
(TA) and RV-incision), isthmus 2 (between RV-incision and pulmonary valve (PV)) and isthmus 3 
(between PV and VSD-patch). Total RV activation time is 108ms with earliest RV activation at the septum 
after QRS-onset and latest activation at the lateral TA coinciding with QRS-offset as demonstrated in 




is the difference between the LAT at isthmus entrance and exit. The isthmus conduction 
velocity (CV) was calculated (isthmus length/conduction time). The CV was measured in 
the direction of the RV propagation wave front during sinus rhythm. In selected patients, 
we have performed differential pacing close to the anatomical isthmus to differentiate 
between slow conduction and block. A slow conducting AI (SCAI) was defined as isthmus 
with low bipolar voltage electrograms (<1.5mV) and a CV<0.50m/sec.14 Based on the first 
quartile of CV distribution in normal controls, a CV ≥0.50m/s and ≤0.63m/s was considered 
borderline CV.14 An AI was classified as having a pre-existing conduction block if either no 
excitable tissue between its anatomical boundaries could be identified or double potentials 
could be recorded along the AI and in addition the RV activation sequence during SR was 
consistent with propagation towards the isthmus from both sites. Septal block was defined 
as a pre-existing conduction block at isthmus 3 in case of perimembranous VSD (absence of 
isthmus 4) or as a pre-existing conduction block at both isthmus 3 and 4 in case of muscular 
VSD. Whether an induced VT was dependent on a SCAI was determined by pace-mapping 
(≥11/12 pace-match) and/or concealed entrainment and/or diastolic activation during VT 
with VT termination by RF-delivery.23 To compare CV within and remote from AI the CV was 
calculated for three additional RV areas: RV septum, RV free wall and low RVOT free wall 
(supplemental methods 4). 
Statistical analysis
Continuous data are presented as mean±standard deviation (SD) or median with inter 
quartile range (IQR) according to distribution. Categorical data are reported as percentages 
or frequencies. The difference in QRS duration measured with LEADs on 12-lead ECG and 
using Carto system was assessed by paired student’s T-test. Patients with and without VT 
were compared using a Student-T, Mann-Whitney U and Chi-Square test where appropriate, 
including subgroups. Associations between QRS duration, RV volumes on CMR and RV 
area on EAM were assessed by Pearson correlation. The relation between (i) QRS duration 
and total RV activation time and (ii) QRS duration and RV activation after QRS-offset was 
illustrated with a scatterplot for all patients and patients with(out) RBBB, dots were marked 
for VT inducibility. QRS duration of RBBB patients were illustrated with an aligned scatterplot, 
according to VT profile. In addition, in these patients, the odds ratio of QRS duration of 
>150ms was calculated for AI properties using logistic regression. SPSS 22.0 for Windows 
was used. P<0.05 was considered significant. 
RESULTS
Patient Population 
Eighty-three patients underwent electrophysiological evaluation. Five patients with an 
incomplete RV map or maps acquired during ventricular pacing were excluded. One patient 
had undergone a prior VT ablation in another center. Subsequently, the study population 
consisted of 78 patients (37±15 years, 67% male) who were repaired at a median age of 5.0 
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years (2.1-8.5). Eleven (14%) had documented sustained VT. QRS duration was 153±29ms. 
Sixty-seven patients (86%) had a broad QRS (>120ms), all RBBB configuration, and 11 patients 
had a narrow QRS. Thirteen patients (17%) had QRS duration ≥180ms. All but 2 patients had 
a preserved LV function and 47 (60%) a preserved RV function. Baseline characteristics are 
provided in table 1.
Electroanatomical mapping and electrophysiological evaluation
RV activation time during SR was 130±24ms. QRS duration did not differ when measured 
on pre-procedural 12-lead ECGs or on CARTO (-1.8ms (95%CI, -4.0–0.4ms) p=0.11). 
The electroanatomical RV surface was 249±66cm² and showed a significant correlation 
with the RVEDV derived from CMR (r=0.68, p<0.001, online figure 1). A RVEDVi of >180ml/
m2 (severely dilated RV) corresponded to a RV surface of >293cm² observed in 15 patients 
(19%). For the entire population, neither the RV surface nor the RV volume correlated to QRS 
duration (r=0.14, p=0.22; r=0.07, p=0.55, respectively, online figure 2).
Table 1. Baseline characteristics
  All patients (n=78)
Age (years) 37±15
Gender (male) 52 (67%)
Total Repair Age (years) 5.0 (2.1-8.5)
Total Repair Age ≥5 years 40 (51%)
TA-patch 29/67* (43%)
Time after repair (years) 30±11
PVR (yes) 16 (21%)
PVR age (years) 31±13
Syncope 5 (6%)
QRS duration 153±29
QRS duration ≥ 180 msec 13 (17%)
Right bundle branch block 67 (86%)
Non-sustained VT on Holter 16/66* (24%)
Class III antiarrhythmic drugs 2 (3%)
LV function preserved 76 (97%)
RV function preserved 47 (60%)
 RVEDV (ml) 242±73
 RVEDV index (ml/m²) 136±39
 RVEDV ≥180 ml/m² 8/68 (12%)
 RVESV (ml) 138±54
 RVESV indexed (ml/m²) 78±30
Cardiac function preserved 46 (59%)
RVEDV, RV end-diastolic-volume; RVESV, RV end-systolic-volume; LAFB, left anterior fascicular block; LV, left 
ventricular; Pts, patients; PVR, pulmonary valve replacement; RBBB, right bundle branch block; RV, right ventricular; 




Anatomical isthmus characteristics and its relation to ventricular 
tachycardia 
All patients had at least one AI and 24 (31%) at least one SCAI, which was SCAI 3 in 
the majority (21/24). One of the 21 patients with SCAI 3 had normal conduction through 
isthmus 4, compensating for septal conduction delay, and one patient had only septal SCAI 4. 
Accordingly, 21 out of 24 patients with any SCAI showed slow conduction at the infundibular 
septum. In 9 patients, a pre-existing block of an AI was observed which was septal isthmus 3 
in all. Thirteen patients had at least one AI with borderline CV, which was also isthmus 3 in all. 
Twenty-four (31%) patients (including all 11 patients with spontaneous VT) were 
inducible for a total of 34 VTs (median VTCL 247ms [230-287]). In 22 patients (92%) with 32 
VTs, a SCAI was the substrate for all clinical and induced VTs (supplemental results 1), which 
was a septal SCAI (3 or 4) in 19 of 22 patients (86%). There was no difference in AI CV between 
the 11 patients with spontaneous and inducible VT (median 0.27m/s (0.20–0.32)) and the 13 
patients with only inducible VT (median 0.34m/s (0.29–0.42), p=0.16). In contrast, a SCAI was 
found in only 2 of 54 patients (4%) without documented or induced VT. Slow conduction 
was not observed remote from the AIs. The electroanatomical CVs for the RV septum, RV free 
wall and RVOT free wall were 1.3±0.3m/s, 1.3±0.3m/s and 0.9±0.2m/s respectively and did 
not differ between patients with or without VT. Fourteen of the 22 patients with SCAI related 
VT underwent successful ablation, defined as non-inducibility of any VT and transection of 
the SCAI. Two patients had no VT, but did have a SCAI 3 and underwent successful ablation 
defined as bidirectional block of the SCAI. All 68 patients without a SCAI (52 at baseline, 16 
after ablation) remained free from VT during follow-up (39±24 months). Detailed acute and 
long-term ablation outcome are added to the supplemental results 2. 
QRS duration, RV activation time and pattern according to VT inducibility 
For the entire population, QRS duration did not differ significantly between patients with 
and without VT (157±35ms versus 151±25ms, p=0.411). However, the RVAT was significantly 
longer in patients with VT (142±23ms versus 125±23ms in non-VT patients, p=0.005), 
table 2. 
A subgroup analysis was performed according to presence or absence of RBBB:
1. In patients with narrow QRS (non-RBBB), QRS duration was similar in patients with 
and without VT (108±11ms and 101±11ms, p=0.429) whereas the RVAT was longer 
in patients with VT (143±30ms vs 91±12ms in patients without VT, p=0.017). In 
all patients, the earliest RV activation during SR was observed simultaneously at 
the distal septum and at the anterior RV free wall followed by rapid propagation 
of activation wavefronts towards the lateral and septal RVOT. The onset of RV 
activation coincided or was close to the QRS-onset (3±12) in patients with and 
without VT (p=0.931). However, QRS-offset and RV activation offset coincided only 
in those without VT. In non-RBBB patients with VT, the latest RV activation exceeded 
QRS-offset by 37±20ms (figure 2D-E and online figure 3) and was located at the exit 
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Table 2. QRS duration and RV activation times according to presence of VT and RBBB
  VT- VT+ p
All patients n = 54 n = 24
 QRS duration (ms) 151±25 157±35 0.411
 RV activation time (ms) 125±23 142±23 0.005
 Interval: QRS onset - RV onset (ms) 23±13 21±17 0.713
 Interval: QRS offset - RV offset (ms) -3±8 6±21 0.040
Non-RBBB n = 5 n = 6
 QRS duration (ms) 101±11 108±11 0.429
 RV activation time (ms) 91±12 143±30 0.017
 Interval: QRS onset - RV onset (ms) 4±12 2±14 0.931
 Interval: QRS offset - RV offset (ms) -5±9 37±20 0.009
RBBB n = 49 n = 18
 QRS duration (ms) 156±20 173±22 0.004
 RV activation time (ms) 129±21 141±22 0.036
 Interval: QRS onset - RV onset (ms) 25±12 28±13 0.305
 Interval: QRS offset - RV offset (ms) -3±9 -4±4 0.524
RBBB, right bundle branch block; RV, right ventricular; VT, ventricular tachycardia; VT -, not inducible for VT; VT+, 
inducible for VT.
site of the VT related SCAI in all patients. These small late activated areas with low 
bipolar voltages did not contribute to the 12-lead surface ECG as demonstrated 
in figure 3. RV size and RV CV remote from the AIs was similar between non-RBBB 
patients with and without VT, table 3.
2. In patients with a RBBB, both QRS duration and RVAT were longer in patients with 
VT as compared to patients without VT (173±22 and 141±22 versus 156±20 and 
129±21, p=0.004 and p=0.036, respectively). Of interest, only 6/18 with VT had 
a QRS duration ≥180ms, but all but one had a QRS duration >150ms. In contrast, 
only 27 (55%) of the 49 RBBB patients without VT had QRS duration >150ms. In all 
RBBB patients, earliest RV activation was observed in a broad area at the mid-to 
basal RV septum, but not at the RV free wall. In patients without VT and normal 
conducting AIs, activation propagated in different wave-fronts: from the RV 
septum through the septal AIs and AI 1, across the inferior wall and across the RV 
free wall, with fusion of wave fronts typically at the basal lateral tricuspid annulus 
being the latest RV activated area (figure 4, online video 1). In patients with VT and 
septal activation delay or delay in AI 1, the latest activated RV area shifted towards 
the lateral RVOT (figure 4, online video 2). The prolongation of the pathway for 
total RV activation resulted in both increase in RVAT and QRS duration. Of note, 
the same activation pattern and prolongation of RV activation and QRS duration 
was observed in 8 patients without VT and a preexisting septal isthmus block 
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Table 3. Right ventricular size, conduction velocity and anatomical isthmuses according to presence of 
VT and RBBB.
  VT- VT+ p
Non-RBBB n=5 n=6
 RV size (cm²) 237±48 247±63 0.785
 CV remote of AI
  RVOT free wall (m/s) 1.1±0.5 1.0±0.2 0.455
  RV free wall (m/s) 1.4±0.4 1.4±0.2 0.800
  RV septal (m/s) 1.3±0.4 1.3±0.1 0.929
  Overall (m/s) 1.3±0.3 1.2±0.1 0.568
 Anatomical isthmus
  SCAI present (yes) 0 (0%) 6 (100%) 0.001
  SCAI (n) 0 (0-0) 2 (1-3) 0.004
   SCAI, isthmus 1 (yes) 0 (0%) 3 (50%) 0.064
   SCAI, isthmus 2 (yes) 0 (0%) 3 (50%) 0.064
   SCAI, isthmus 3 (yes) 0 (0%) 5 (83%) 0.006
   SCAI, isthmus 4 (yes) 0 (0%) 0 (0%)
  Longest AI conduction time (ms) 17±11 73±17 <0.001
  Slowest AI CV (m/s) 0.8 (0.7-0.9) 0.3 (0.2-0.4) 0.004
  Blocked septal anatomical isthmus 0 (0%) 0 (0%)
RBBB n=49 n=18
 RV size (cm²) 254±64 241±79 0.489
 CV remote of AI
  RVOT free wall (m/s) 0.9±0.2 0.9±0.3 0.997
  RV free wall (m/s) 1.3±0.3 1.3±0.2 0.639
  RV septal (m/s) 1.3±0.3 1.2±0.3 0.228
  Overall (m/s) 1.2±0.2 1.1±0.1 0.307
 Anatomical isthmus
  SCAI present (yes) 2 (4%) 16 (89%) <0.001
  SCAI (n) 0 (0-0) 1 (1-1) <0.001
   SCAI, isthmus 1 (yes) 0 (0%) 3 (17%) 0.003
   SCAI, isthmus 2 (yes) 0 (0%) 1 (6%) 0.096
   SCAI, isthmus 3 (yes) 2 (4%) 14 (78%) <0.001
   SCAI, isthmus 4 (yes) 0 (0%) 2 (11%) 0.018
  Longest AI conduction time (ms) 22±12 65±29 <0.001
  Slowest AI CV (m/s) 0.7 (0.6-0.9) 0.3 (0.2-0.4) <0.001
  Blocked septal anatomical isthmus 8 (16%) 1 (6%) 0.252
CV, conduction velocity; RBBB, right bundle branch block; RV, right ventricular; RVOT, RV outflow tract; SCAI, slow 
conducting anatomical isthmus; TA, tricuspid valve annulus; VT, ventricular tachycardia; VT -, not inducible for VT; 
VT+, inducible for VT.  
the RV activation was recorded 26±12ms after the onset of the QRS both in patients 
with and without VT (p=0.305). Furthermore, QRS-offset and RV activation offset 




Figure 3. Patient without RBBB, but with VT. RV electroanatomical maps obtained during sinus rhythm 
of a 35 years old female, who presented with near-collapse, inducible for a fast VT (VTCL 230ms), 
modified posterior view. Left panel (A): Voltage map color-coded for bipolar voltage. Right panel (B): 
Activation map color-coded for activation time according to bar. QRS duration was 109ms (on/offset 
-43/66ms), the total RV activation time was 147ms (on/offset -41/106ms). RV activation exceeds QRS-
offset (purple area on right map, not visible on ECG) by 40ms, the latest activated area was located 
in the low voltage area between the pulmonary valve (PV) and the VSD-patch (i.e. isthmus 3). There 
was capture at each site across isthmus 3 and fusion at the exit region of isthmus 3 suggesting slow 
conduction through isthmus 3. In addition, a slow conducting or blocked isthmus can be furthered 
differentiated by differential pacing close to the isthmus. At this site (*) of isthmus 3 the critical isthmus 
of the induced VT was identified. TA, tricuspid annulus. 
figure 3). As in patients with narrow QRS, CV of the RV remote from AIs and the RV 
endocardial surface did not differ between patients with and without VT (table 3). 
Interplay between QRS-duration, RV size, SCAI and VT in patients with RBBB 
Of the 18 patients with RBBB and VT, 17 had a QRS duration >150ms, 16 a SCAI, but only 
4 a severely dilated RV (figure 5). Accordingly, in patients with RBBB and VT, a SCAI was 
the most prevalent mechanism for QRS prolongation. The only patient with a RBBB, VT and 
a QRS duration<150ms had a SCAI 3 related VT. However, the second fast conducting septal 
isthmus 4 prevented septal activation delay and QRS prolongation.
In contrast, of the 49 RBBB patients without VT, only 27 had a QRS duration>150ms. 
Of these 27 patients, the majority (n=16 (59%)) had either a severely enlarged RV without 
SCAI (n=10 (37%)) and/or a preexisting blocked septal isthmus (n=8 (30%)) as mechanisms 
for QRS prolongation (figure 5). In contrast, none of the 22 patients without VT and QRS 
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Figure 4. RV activation in patients with RBBB according to absence/presence of a slow conducting 
anatomical isthmus. Panel A1-2:12-lead ECGs of a patient without VT (A1) and with VT (A2). Panel B1-2: 
Electroanatomical reconstruction of the RV (modified posterior view) displayed as color-coded voltage 
map (left, purple indicates normal bipolar voltage) and activation map (right, red indicates early 
activation, purple late activation). Anatomical isthmus 3 between pulmonary valve (PV) and VSD-patch 
(grey dots) is marked with white brackets. B1: RV activation map demonstrates RV activation trough 
a normal conducting anatomical isthmus 3 with fusion of the propagation wavefronts at the lateral 




duration ≤150ms had either a severely dilated RV or a blocked septal isthmus. These data 
suggest that in contemporary rTOF, a QRS duration between120 and 150ms is solely due to 
the postoperative RBBB.
The presence of RBBB with a QRS-duration >150ms was strongly associated with 
the presence of a slow conducting or blocked isthmus (OR 13.8 (95% CI, 2.9-66.2), p=0.001). 
After exclusion of patients with severely enlarged RV (n=14), the odds ratio of a QRS-
duration>150ms for slow conducting or blocked AI was 16.6 (95% CI, 3.3– 84, p=0.001).
DISCUSSION 
To the best of our knowledge, this is the first study using detailed 3D RV electroanatomical 
mapping to assess the relation between QRS duration, RV size and RV activation during 
SR and the substrate for reentry VT in patients with rTOF. We could demonstrate that rTOF 
patients with a narrow QRS can be at risk for life-threatening VT related to slow conducting 
anatomical isthmuses (SCAI). Rapid activation through the distal specific conduction system 
with fusion of wavefronts at the infundibulum can mask slow conduction in septal AIs. In these 
patients, the surface ECG does not contribute to substrate identification. In contrast, in rTOF 
Figure 5. QRS duration according to VT inducibility and underlying mechanisms for QRS prolongation. 
Aligned dot plot. RV, right ventricle; VT, ventricular tachycardia; VT-, non-inducible for VT;  VT+, inducible 
for VT; *, other VT substrates; **, patient with double septal isthmus (isthmus 3 with slow conduction 
and isthmus 4 with normal conduction velocity).
conduction delay at anatomical isthmus 3 (i.e. slow conducting anatomical isthmus) causing a shift in 
the fusion site of activation wavefronts towards the RVOT. Panels C1-2 and D schematically illustrate 
the RV activation in presence of normal conducting anatomical isthmus 3 (C1) and slow conducting 
anatomical isthmus 3 (C2) causing a shift in RV fusion site (D) and QRS prolongation. PV, pulmonary 
valve; QRSd, QRS duration; RV, right ventricle; RVOT, RV outflow tract; vs, versus.
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patients with a preexisting RBBB at any level, VT related SCAI further prolong the pathway 
for total RV activation resulting in QRS duration>150ms. A similar QRS prolongation in 
rTOF patients with RBBB but without SCAI can be observed in those with a severely dilated 
RV or with preexisting septal isthmus block. After exclusion of severe RV dilatation, a QRS 
duration>150ms is highly predictive for conduction delay at the infundibular septum as 
potential substrate for VT. To further distinguish between conduction delay within an AI as 
substrate for VT and conduction block requires electroanatomical mapping.
Ventricular arrhythmias and SCD in rTOF
Monomorphic VT (MVT) is the most common documented arrhythmia subtype in rTOF.6, 7, 14 
Considering the typically short cycle length, MVTs may lead to SCD even if the biventricular 
function is preserved.4, 5, 24 Electroanatomical mapping studies have demonstrated that 
the dominant underlying mechanism of MVT is macro-reentry using SCAI located in 
the RVOT.14, 23 In the present cohort, a SCAI was the substrate for all clinical and induced VTs 
in 22/24 patients. 
QRS prolongation as risk factor for VT and SCD
A prolonged QRS duration has consistently been associated with both MVT and SCD in 
rTOF.8-10 In a large series of 182 patients, all 13 patients with (near-missed) SCD had QRS 
≥180ms, which was observed in only 5.3% of patients without an event. Of importance, 
all 9 SCD survivors underwent PES and were inducible for monomorphic fast reentry 
VT, suggesting that MVT had caused the event and that QRS prolongation may predict 
the substrate for reentry VT.9 PES performed in 134 unselected rTOF patients confirmed 
the association between QRS  ≥180ms and MVT. A QRS≥180ms was 35% sensitive and 97% 
specific for inducibility of any MVT and 100% sensitive and 96% specific for inducibility 
of the clinical VT.8 A subsequent multicenter study demonstrated that QRS ≥180ms was 
the strongest independent predictor for VT with a remarkable HR of 41.9 (14.7-119.4).10 In 
more recent cohorts, the reported sensitivity of QRS ≥180ms for death or VT was much lower 
(28%-53%) and a cutoff value of 170ms has been suggested (sensitivity 53%, specificity 
86%).11, 12 Similar, in our cohort QRS ≥180ms was observed in only 6/24 (25%) patients with 
VT and in 7/54 (13%) without VT. 
A modern transpulmonary approach may prevent a postoperative RBBB. As a consequence, 
an important number of contemporary rTOF patients has a narrow QRS without RBBB 
which may influence the predictive value of a prolonged QRS for VT/SCD if patients with 
and without RBBB are not separated. We could only demonstrate a significant difference 
in QRS duration between patients with and without VT after excluding the 11 (14%) rTOF 
patients with a narrow QRS. Of importance, the use of smaller transannular patches may 
reduce pulmonary valve regurgitation and RV dilatation. As a result, contemporary patients, 
with postoperative RBBB may still have less additional QRS prolongation, as the delayed 




patients with a postoperative RBBB, the optimal QRS cut-off for risk stratification needs to 
be redefined. 
RV activation in rTOF patients with narrow QRS
All patients with narrow QRS showed early simultaneous RV activation at the anterior wall 
and the septum via distal ramifications of the conduction system with further propagation 
towards the anterolateral RVOT and the infundibular septum.25 In the 6 patients with narrow 
QRS and isthmus related VT, fusion of activation wavefronts during SR was typically observed 
at the infundibular septum. Late activation after QRS offset was restricted to a small area 
with low bipolar voltages, therefore not contributing to the surface QRS. Such late potentials 
are also often observed in patients with scar related VTs of other etiologies. Of importance, 
in our series, a narrow QRS did not exclude a substrate for life-threatening VT. Although not 
performed in this study, signal averaged ECG (SAECG) may detect late activated infundibular 
regions with low voltages. Previous studies that have assessed the association between 
SAECG and ventricular arrhythmias were either performed in heterogeneous groups 
of patients with congenital heart disease or have looked at any ventricular arrhythmia, 
including PVCs and non-sustained VT as outcome parameter, with conflicting results.26, 27 
One prior study conducted in 66 rTOF patients undergoing repair via a RV ventriculotomy 
with subsequent RBBB could demonstrate that patients who developed sustained VT (n=12, 
18%) had a longer filtered QRS on SAECG compared to those without VTs (165±17ms versus 
179±18ms, p=0.01).28 Of interest, both additional SAECG criteria (RMS and HFLA), consistent 
with late activation of low amplitude regions, did not differ between groups. The predictive 
value of SAECG for sustained VT in contemporary rTOF patients with a narrow QRS has 
never been evaluated.Of interest, two patients with a narrow QRS had a severely dilated 
RV suggesting that in patients with rapid conduction through the specific conduction 
system rather than primary myocardial activation, RV size does not significantly contribute 
to QRS duration.
RV activation in rTOF patients with RBBB
In patients with RBBB, rapid conduction via the specific conduction system is interrupted and 
RV activation depends on slower myocardial impulse propagation. RBBB after surgery can be 
present at three levels; the proximal right fascicle, the distal ramification after infundibular 
resection or the peripheral conduction system secondary to the right ventriculotomy.29 Of 
interest, a vertical ventriculotomy alone can result in a RBBB pattern with QRS prolongation 
by an average of 39ms.13 Irrespective of the level of block, the basal lateral RV and RVOT 
are activated late.29 In our patients with RBBB and no additional area of conduction delay, 
the earliest RV activation during SR was always observed at the septum and excitation 
wavefronts were merging at the basal lateral tricuspid annulus. In patients with septal 
conduction delay due to SCAI or isthmus block, the pathway of impulse propagation was 
prolonged with a shift of latest activation towards the lateral RVOT. This latest area had 
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preserved voltage and contributed to prolongation of both the total RV activation time 
and QRS duration. This is in contrast to other forms of structural heart disease with scar 
related VT, where slow conduction within the scar results in late potentials of low amplitude 
inscribing after QRS offset. 
QRS duration: global vs localized delay
In our series, all RBBB patients had normal CV remote from the anatomically defined isthmuses 
(i.e. normal global CV). Despite normal global CV, severe RV dilation can also prolong 
the pathway for myocardial impulse propagation leading to an increase in QRS duration. 
Fourteen of the 44 RBBB patients with QRS >150ms had a severely enlarged RV. In 8/14 QRS 
prolongation was solely due to longer RV activation time of the dilated RV, in 6/14 patients 
a SCAI or isthmus block further contributed to QRS prolongation. This data supports that 
local rather global myocardial conduction delay or block contributes to QRS prolongation 
in the majority of patients. The localized conduction delay or isthmus block resulted in 
a shift of latest activation towards the RVOT. The observed shift in latest activation provides 
a potential explanation for prior findings on right ventricular dyssynchrony showing that 
QRS duration was strongly associated with the delay in RVOT shortening, which was more 
pronounced if QRS was ≥155ms. The delay increased to more than the upper 95% in all pts 
with a QRS >165ms.30
The link between QRS duration and VT in rTOF
According to our data, in the absence of a severely enlarged RV, a QRS >150ms is highly 
suspicious for the presence of a SCAI as potential substrate for VT. This finding provides an 
important link between prolonged QRS and VT substrate in rTOF patients with RBBB. In only 
one patient of our cohort, the VT substrate, i.e. the SCAI, did not influence QRS duration 
because of the presence of a second and normal conducting septal isthmus. A QRS>150ms 
can also be observed in patients with preexisting isthmus block. Information on isthmus 
block can be sometimes derived from the operation records, e.g. description of an absent 
infundibular septum. If not conclusive, EAM is required to distinguish slow conduction as 
substrate for VT from pre-existing block. 
LIMITATIONS
This study is limited by the cross-sectional-design. In the current study, rTOF patients who 
were considered at risk for VT or who presented with spontaneous VT underwent PES with 
RV mapping. The results can therefore not be applied to the general rTOF population. 
In 5 patients with a RBBB, we could not identify the mechanism of QRS >150ms. As 
electroanatomical CV was measured only at the endocardium and not at the epicardium, 
additional epicardial and transmural conduction delay cannot be excluded. In addition, 





In rTOF with pre-existing RBBB, the increased QRS duration is frequently due to localized 
conduction delay across the AI rather the global delay. These SCAIs prolong the pathway for 
RV activation and QRS duration providing an important causal link between QRS width and 
substrate for VT. After exclusion of severe RV dilatation, a QRS >150ms is highly predictive for 
a SCAI and may justify electroanatomical mapping to distinguish between a slow conducting 
and blocked AI. A narrow QRS in rTOF patients does not exclude SCAI and the risk for VT. 




Competency in Medical Knowledge
The dominant substrate for ventricular tachycardia (VT) in repaired Tetralogy of Fallot (rTOF) 
are slow conducting anatomical isthmuses (SCAI). In rTOF patients with right bundle branch 
block (RBBB), SCAI increase RV activation time and QRS duration. In rTOF patients with 
a narrow QRS, SCAI does not influence QRS duration. 
Competency in Patient Care 1
In rTOF patients with RBBB, a QRS duration >150ms is highly suggestive for presence of a SCAI 
or blocked isthmus, in particular in patients without severe RV dilatation. Electroanatomical 
mapping can distinguish SCAI from isthmus block and may become an important tool for VT 
substrate identification.
Competency in Patient Care 2
In repaired TOF patients with a narrow QRS, a VT substrate cannot be excluded. 
Translational Outlook
Data are based on a cross-sectional study in a selected group of rTOF patients with 
documented sustained VT, considered at risk for VT and/or with indication for re-operation. 
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LEADS (Leiden ECG Analysis and Decomposition Software) is a MATLAB based computer 
program. LEADS automatically detects all QRS complexes of a 12 lead ECG based on signal-
to-noise ratio, on interbeat interval time and QRS-T morphology. After the automated beat 
selection, each individual beat is reviewed by the analyst who can optimize beat selection. 
The selected beats are then averaged into a single QRS complex, subsequently QRS duration 
can be measured with high accuracy.
2. Induction protocol.
Induction protocol was performed at ≥2 right ventricular (RV) sites, always including 
RV-apex and RV outflow tract (RVOT) close to the infundibular septum, using three drive 
cycle lengths (400, 500 and 600ms) with up to three extra stimuli down to refractoriness 
before and during isoproterenol infusion (2-10μg/min).
3. Electroanatomical identification of the anatomical isthmuses. 
During RV mapping, high out pacing (≥10 mA, 2ms) was performed at low voltage sites 
(<1.5mV) to identify electrically unexcitable tissue (patches and surgical scars), which 
together with the tricuspid annulus and pulmonary valve form the boundaries of the four 
potential anatomical isthmuses.
4. Non-anatomical isthmus conduction velocity (CV) measurement.
To compare CV within and remote from the anatomically defined isthmuses, CV was 
calculated for three additional RV areas remote from the anatomical isthmuses: RV septum, 
RV free wall and RV outflow tract free wall. For this purpose, the RV activation maps during 
sinus rhythm were displayed as isochronal maps and the CV was calculated in the direction 
of the endocardial propagation wave front. CV measurements were performed at ≥3 sites/
area and averaged per area. Non-anatomical isthmus CV was defined as the average of all CV. 




1. VT related substrates
A total of 34 VTs were induced. Thirty-two of the 34 VTs were related to a SCAI. The 2 
remaining VT that were not related to a SCAI were observed in 2 patients with advanced 
heart failure and poor RV function, 1 VT was related to a large free wall scar and 1 VT was due 
to a focal VT mechanism. Participation of a SCAI in the VT circuit was based on pace-mapping 
in 22 (due to the fast and hemodynamically not tolerated VT), entrainment mapping in 3 
and 7 VTs were related to a SCAI based on diastolic activity during VT with VT termination 
by RF-delivery.
2. Acute and long-term VT ablation outcome data
A total of 24 patients were inducible for VT. Twenty-two of these 24 patients had VT related 
to a SCAI and 14 of these 22 patients underwent successful ablation. Another two patients 
had SCAI, but were not inducible for VT. Both of these two patients underwent successful 
ablation, defined as bidirectional block of the SCAI. In addition, 52 patients had no SCAI 
and were not inducible for VT. All 68 patients without a SCAI (52 at baseline and 16 after 
successful SCAI ablation) remained free from VT during long-term follow-up (39±24 months). 
Eight patients with SCAI related VT had a SCAI during follow-up due to failed ablation (n=6) 
or no ablation (n=2). Four of these 8 patients experienced VT during long-term follow-up 
(35±19 months, p<0.001). In addition, there were two patients with VT that was not related 








































































































































































































































































































































































































































































































































Online figure 3. Schematic overview to demonstrate key similarities and differences in QRS duration and 
RV activation time between patients with and without VT in absence (non-RBBB) or presence of RBBB. 
Non-RBBB patients with VT show RV activation after QRS-offset, which is not observed in non-RBBB 
patients without VT. In non-RBBB patients with VT, parts of the VT substrate (red, VT+) are activated 
after QRS-offset, but not contributing to the 12-lead ECG. RBBB patients with VT have a significantly 
longer (red Δ) QRS duration and RV activation time than those without VT. Both in patients with and 
without VT, RV activation starts after QRS-onset and ends with the QRS-offset. RBBB, right bundle 
branch block; RV, right ventricle; VT, ventricular tachycardia; VT -, not inducible for VT; VT+, inducible 
for VT; Δ, difference. 
SUPPLEMENT - VIDEO LEGEND
Video 1: A right ventricular (RV) electroanatomical activation map showing propagation 
during sinus rhythm of a rTOF patient with right bundle branch block and with normal 
conducting anatomical isthmuses. The earliest activation can be observed in a broad area 
at the mid tot basal RV septum. The activation propagates in different wavefronts through 
the septal anatomical isthmus and non-septal anatomical isthmus, across the inferior wall 
and across the RV free wall with fusion of the wavefronts at the basal lateral tricuspid annulus. 
Video 2: A right ventricular (RV) electroanatomical activation map showing propagation 
during sinus rhythm of a rTOF patient with right bundle branch block and VT related to 
a slow conducting septal anatomical isthmus between the ventricular septal defect patch and 
the pulmonary valve. The earliest activation can be observed in a broad area at the mid 
to basal RV septum. The activation propagates in different wave fronts through the septal 
anatomical isthmus, across the inferior wall and across the RV free wall. The delay at the septal 
anatomical isthmus results in a shift of fusion of wavefronts towards the lateral right 
ventricular outflow tract, which prolongs the pathway for RV activation and QRS duration. 
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In Tetralogy of Fallot (TOF), the dominant ventricular tachycardia (VT) substrate are slow 
conducting anatomical isthmuses. Surgical correction has evolved, which might have 
influenced isthmus presence and dimensions.
Methods
One-hundred-forty-two post-mortem TOF specimens (84/58 corrected/uncorrected) were 
studied for isthmus presence. Isthmus 1 is located between the tricuspid annulus and right 
ventricular (RV) outflow tract (RVOT)-patch/RV-incision, Isthmus 2 between RVOT-patch/RV-
incision and pulmonary valve, Isthmus 3 between pulmonary valve and ventricular septal 
defect (patch), Isthmus 4 between ventricular septal defect (patch) and tricuspid annulus. 
Isthmus width and thickness were measured. 
Results
Of 84 corrected post-mortem TOF specimens (death: 6.6 years (4.0-11.5)) 83 demonstrated 
Isthmus 1 (99%, width=25±10mm, thickness=5±2mm), 35 Isthmus 2 (42%, width=10±9mm, 
thickness=3±2mm), 83 Isthmus 3 (99%, width=10±6mm, thickness=5±2mm), and 5 Isthmus 
4 (6%, width=4±2mm, thickness=2±1mm). Transatrial-transpulmonary correction (n=49) 
as compared to  transventricular correction (n=35) prevented Isthmus 2 (0% versus 100%, 
p<0.001). Transatrial-transpulmonary correction at age <1year (n=7) as compared to ≥1year 
(n=42) required a smaller transannular RVOT-patch (28±15 versus 45±14mm, p<0.001). 
Mode and timing of correction did not influence presence and dimensions of Isthmus 3. In 
corrected and uncorrected TOF specimens (death 1.8 years (0.5-6.6)), the range of Isthmus 3 
dimensions was broad (width: min=2mm, max=32mm; thickness: min=1, max 13mm) across 
all ages. Isthmus 3 width and thickness were strongly correlated (r=0.65, p<0.001). 
Conclusions
In TOF, the current routine use of transatrial-transpulmonary correction prevents Isthmus 
2. Correction <1year reduces transannular-patch size, which may influence Isthmus 1 width 
later in life. Mode and timing of correction did not change prevalence and dimensions of 
Isthmus 3, which dimensions varied widely in uncorrected and corrected TOF. 




Tetralogy of Fallot (TOF) is the most prevalent cyanotic congenital heart disease.1 
The population of adults with corrected TOF is progressively growing due to improved 
surgical techniques extending survival.1, 2 Late morbidity and mortality in TOF are often 
caused by ventricular arrhythmias (VA).3, 4 The majority of VA are monomorphic re-entrant 
ventricular tachycardias (VTs).5 The dominant substrate for these re-entrant monomorphic 
VTs are slow conducting anatomical isthmuses located in the right ventricular (RV) outflow 
tract (RVOT).6-8 Anatomical isthmuses with slow conduction are significantly narrower as 
compared to anatomical isthmuses without slow conduction.7
 Presence and dimensions, i.e. width and thickness, of the isthmuses are the result of both 
the anatomical features of the malformation itself and of the surgical correction. Surgical 
techniques have evolved over time. Nowadays, surgeons preferably use a transatrial-
transpulmonary approach instead of the transventricular approach.9 In addition, the timing 
of repair has shifted from the first decade of life to the first year of life.10 The aim of the current 
study was twofold (1) to assess the presence and dimensions of the isthmuses according 
to mode and timing of correction in post-mortem TOF specimens, (2) to gain insight into 
the natural growth and the effect of correction of the isthmus between the pulmonary valve 
(PV) and ventricular septal defect (VSD). This isthmus, that is part of the malformation itself, 
is the most prevalent arrhythmogenic isthmus in TOF.6, 7
Methods 
Specimen selection 
This study was undertaken in accordance with the local ethics committee and the Dutch 
regulation for the proper use of human tissue for medical research purposes. The Leiden 
Collection of malformed hearts (Department of Anatomy and Embryology, Leiden University 
Medical Centre, Leiden, The Netherlands), a collection consisting of hearts preserved in 
ethanol and glycerine dating from the nineteen fifties to the present era, was reviewed for 
corrected and uncorrected TOF hearts. The anatomical spectrum of TOF phenotype is broad; 
in the current study specimens with ‘classical’ TOF and TOF with double outlet ventricle 
(DORV, defined as >50% overriding of the aortic annulus over the ventricular septum) 
were included. Specimens with sub-aortic VSD with valvular/muscular pulmonary atresia, 
concomitant atrioventricular septal defect and hearts too damaged to be analysed were 
excluded from the analysis. A total of 142 TOF hearts were included. 
Specimens characteristics (clinical data)
The (anonymized) medical records of the 84 corrected and 58 uncorrected patients from 
whom the specimens were obtained between 1950 and 2007, were reviewed for age, gender, 
palliative surgery, corrective surgery and mode of death. If palliative surgery was performed, 
the following data was collected: date and type, i.e. Brock (dilatation of the PV/membranous 




(ascending aorta-right pulmonary artery) or Blalock Taussig shunt (subclavian artery-
pulmonary artery). If correction was performed, the following data was collected: date 
and mode, i.e. transannular RVOT-patch/incision, non-transannular RV-incision/patch, VSD 
closure and infundibular resection. 
Specimen measurements
All included specimens, if corrective surgery was performed, were visually assessed for 
mode of correction, i.e. transannular RVOT-patch (including size) or RV-incision, non-
transannular RV-incision/patch, VSD closure and infundibular resection. If a discrepancy was 
present between operation reports and visual assessment, visual assessment determined 
the definitive classification. The transventricular approach was defined by a ventriculotomy 
into the RV myocardial wall remote from the PV. The transatrial-transpulmonary approach 
was defined by correction via the tricuspid valve and/or PV and, if required, division of 
the pulmonary annulus with a limited ventriculotomy extended from the valve annulus and 
reconstructed by a transannular patch.11
All included specimens were assessed for the presence of the four potential isthmuses 
(Figure 1).6, 8 The first potential isthmus is bordered by the tricuspid annulus and a RVOT-patch 
or RV-incision, the second potential isthmus is bordered by the PV and a non-transannular 
RV-incision/patch, the third potential isthmus is bordered by the VSD-patch and PV, and 
the fourth potential isthmus is bordered by the VSD-patch and the tricuspid annulus (only 
present in case of a VSD with muscular postero-inferior rim, i.e. non-perimembraneous 
VSD). Isthmus 1 and 2 are the result of the correction, therefore only assessed in corrected 
specimens. Isthmus 3 and 4 are due to the malformation, therefore assessed in all specimens. 
The width and thickness of the identified isthmuses were measured (Figure 1). Isthmus 
width was defined as the shortest distance between the two bordering anatomical structures, 
ea. the shortest distance between the PV and VSD(-patch) in case of isthmus 3. The thickness 
of the isthmuses was assessed using a straight biceps with a built-in calliper. If isthmus 
thickness could not be assessed with a straight biceps due to anatomical reasons, e.g. closed 
VSD, a curved biceps with calliper was used. The size of the RV was defined as the shortest 
distance between the RV apex and the PV (to include the RVOT). Isthmus dimensions (width 
and thickness) were corrected for RV size. 
Statistical analysis
Continuous data are reported as mean±standard deviation (SD) or median with inter quartile 
range (IQR) according to data distribution. Categorical data are presented as frequencies 
or percentages. In case of two groups, groups were compared using a student’s T-test, 
Mann-Whitney U test or Chi-Square test where appropriate. TOF specimens corrected with 
a transventricular approach were compared to TOF specimens corrected with a transatrial-
transpulmonary approach. Furthermore, TOF specimens with a transatrial-transpulmonary 
correction <1 year of age were compared TOF specimens with a transatrial-transpulmonary 
correction ≥1 year. To compare isthmus dimensions between these two age groups, isthmus 
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size was adjusted for RV size if an association was present based on Pearson correlation. 
Uncorrected and corrected TOF specimens were compared for isthmus 3 width and thickness. 
In addition, the associations between (i) isthmus 3 width and age, (ii) isthmus 3 thickness 
and age, and (iii) isthmus 3 width and thickness were illustrated with scatterplots for (un)
corrected TOF specimens and were evaluated by Pearson correlation. A p-value <0.05 were 
considered statistically significant. SPSS software (20.0, SPSS Inc, Chicago, USA) was used.
Figure 1. Overview of anatomical isthmuses. Panel A-C: Schematic overview of anatomical isthmuses: 
isthmus 1 between tricuspid annulus (TA) and right ventricular (RV) outflow tract (RVOT) patch / 
RV-incision, isthmus 2 between non-transannular RV-incision and pulmonary valve (PV), isthmus 3 
between ventricular septal defect (VSD) patch and PV, isthmus 4 between VSD-patch and TA. Panel D-F: 
Anatomical specimens with isthmus 1, 2 and 3 (F: isthmus 4 absent, because of non-muscular VSD). 
Panel G-I: RVOT in detail of panel D-F, illustrating isthmus width. AO, aorta; PA, pulmonary artery; RA, 





Corrected specimens: Patient characteristics 
The cohort consisted of 84 corrected patients (60% male). The median age was 6.6 (4.0–11.5) 
years, the youngest age was 1 month, 20 patients (24%) were ≥12 years, the oldest patient 
was 57 years (Table 1, Figure 2). RV size was 64±17mm. Thirty-two TOF patients (38%) also 
had DORV. Thirty-nine (46%) patients (median age 3.0 years (1.4–4.9)) underwent palliative 
surgery before correction, details are provided in Supplement A1. Patients were corrected at 
median age of 6.5 years (4.0–10.5) with a transannular RVOT-patch/incision in 63% of patients 
(n=53) and with a non-transannular RV-incision/patch in 42% of patients (n=35). Of these 










Age (y) 6.6 (4.0-11.5) 7.7 (4.8-14.4) 6.4 (2.0-8.8) 0.053
Age category (y)
 <1 8 (10%) 1 (3%) 7 (14%) 0.249
 1 - <4 13 (16%) 3 (9%) 10 (20%)
 4 - <8 29 (35%) 14 (40%) 15 (31%)
 8 - <12 14 (17%) 6 (17%) 8 (16%)
 12 - <18 11 (13%) 6 (17%) 5 (10%)
 18 or older 9 (11%) 5 (14%) 4 (8%)
Gender (male) 50 (60%) 24 (69%) 26 (53%) 0.153
RV size (mm) 64±17 65±14 62±19 0.444
DORV 32 (38%) 13 (37%) 19 (39%) 0.879
Correction
 Year 70 (‘63-‘74) 69 (‘64-‘71) 71 (‘63-‘77) 0.120
 Age (y) 6.5 (4.0-10.5) 7.7 (4.8-14.3) 6.4 (2.0-8.3) 0.023
 TA: RVOT-patch or incision 53 (63%) 5 (14%) 48 (98%) <0.001
  Transannular RVOT-patch 52 (62%) 5 (14%) 47 (96%) <0.001
  Transannular RVOT-incision 1 (1%) 0 (0%) 1 (2%) 0.099
 Non-TA: RVOT-patch or incision 35 (42%) 35 (100%) 0 (0%) <0.001
  Non-transannular RVOT-patch 4 (5%) 4 (11%) 0 (0%) 0.015
  Non-transannular RVOT-incision 31 (37%) 31 (89%) 0 (0%) <0.001
 Infundibular resection 76/82* (93%) 33 (94%) 43/47* (92%) 0.631
Death
 Death perioperative 78 (93%) 34 (97%) 44 (90%) 0.197
  Cardiac, all 50/68* (74%) 23/31* (74%) 27/37* (73%) 0.910
 Death non-perioperative 6 (7%) 1 (3%) 5 (10%)
  Cardiac 3/4* (75%) 1 (100%) 2/3* (67%) 0.505
  Time from correction to death (y) 0.4 (0.2-17.1) 0.4 0.4 (0.1-22.8) 1.000
DORV, double outlet RV; mm, millimeter; OT, outflow tract; RV, right ventricle; TA, transannular; y, year; 
*, missing data.
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patients, 5 had a transannular RVOT-patch/incision as well as a separate non-transannular 
RV-incision/patch. Seventy-eight patients (93%) died during the perioperative period 
(Figure 2), from cardiac causes in 74% of the cases. The remaining six patients died a median 
of 0.4 years (0.2–17.1) years after correction, from cardiac causes in 75% of the cases. 
Figure 2. Overview of age, timing of correction and survival after correction of 84 corrected patients 
between 1936 and 2007 covering a period of 81 years, according to mode of correction. After 1975, all 
patients underwent transatrial-transpulmonary correction, except for one patient (number 81, marked 




Thirty-five patients (42%) were corrected with a transventricular approach and 49 
patients (58%) were corrected with transatrial-transpulmonary approach. Patients with 
a transatrial-transpulmonary approach were corrected at younger age as compared to 
patients with a transventricular approach (6.4 (2.0–8.3) versus 7.7 (4.8–14.3) years, p=0.023) 
and more often with the use of a transannular RVOT-patch (96% versus 14%, p<0.001). 
Corrected specimens: the influence of mode of correction 
Isthmus 1, the isthmus between tricuspid annulus and RV-incision/RVOT-patch, and isthmus 
3, the isthmus between PV and VSD-patch, were both present in 99% of the patients (n=83) 
(Table 2). Isthmus 2, the isthmus between the PV and a non-transannular RV-incision/patch 
was present in 35 patients (42%). Isthmus 4, the isthmus between the tricuspid valve and 
VSD-patch (in cases with a non-perimembraneous VSD), was present in only 5 patients (6%). 
The width and thickness of isthmus 1, 2, 3 and 4 were respectively 25±10 by 5±2mm, 10±9 
by 3±2mm, 10±6 by 5±2mm and 4±2 by 2±1mm (Table 2). 
There was no difference in presence of isthmus 1, 3 and 4 between both modes of 
correction. However, isthmus 2 was present in all 35 patients with a transventricular correction 
and absent in all 49 patients with a transatrial-transpulmonary correction (p<0.001). Of 
interest, in our cohort, the transventricular correction was no longer observed after July 
1975 except for in 1 patient (Figure 2 – patient 81). This patient had an isolated RV-patch 











 Present (n) 83 (99%) 35 (100%) 48 (98%) 0.395
 Width (mm) 25±10 27±9 23±9 0.122
 Thickness (mm) 5±2 5±2 6±2 0.036
Isthmus 2
 Present (n) 35 (42%) 35 (100%) 0 (0%) <0.001
 Width (mm) 10±9 10±9
 Thickness (mm) 3±2 3±2
Isthmus 3
 Present (n) 83 (99%) 34 (97%) 49 (100%) 0.234
 Width (mm) 10±6 10±5 10±7 0.489
 Thickness (mm) 5±2 5±2 5±3 0.666
Isthmus 4
 Present (n) 5 (6%) 2 (6%) 3 (6%) 0.938
 Width (mm) 4±2 4±1 4±3 1.000
 Thickness (mm) 2±1 3±1 2±1 0.333
Mm, millimeter. 
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due to aberrant coronary anatomy (LAD from RCA, crossing the anterior RVOT just below 
the PV (Supplement A2)). Thus, after 1975, TOF patients without major coronary aberrancy 
underwent transatrial-transpulmonary correction and subsequently isthmus 2 was no 
longer encountered. Dimensions of isthmus 3 and 4 did not differ between both modes 
of correction. However, isthmus 1 was significantly thicker in patients with a transatrial-
transpulmonary approach (p=0.036). 
Corrected specimens: the influence of timing using the transatrial-
transpulmonary correction
In the 49 TOF patients corrected with a transatrial-transpulmonary approach, isthmus 1, 3 
and 4 were present in 98%, 100% and 6% of the patients and a transannular RVOT-patch 
(size 43±15mm) was used in 47 patients (96%). In these 49 patients, width and thickness of 
isthmus 1, 3 and 4 were 23±9 by 6±2mm, 10±7 by 5±3mm and 4±3 by 2±1mm respectively 
(Table 3). Width of isthmus 1 and 3 was associated with RV-size (r=0.67, p<0.001 and 
r=0.34, p<0.018). 
Of interest, the transannular RVOT-patch was 1.6 times smaller in the 7 patients corrected 
with a transatrial-transpulmonary approach below the age of 1 year (28±15mm) as compared 
Table 3. Corrected specimens: Isthmus properties after transatrial-transpulmonary correction according 





 <1 year (n=7)
Correction
 ≥1 year (n=42) p
Isthmus 1
 Present (n) 48 (98%) 6 (86%) 42 (100%) 0.013
 TA-patch (size) 43±15 28±15 45±14 0.009
 Width (mm) 23±9 15±2 24±9 <0.001
 Width (mm) / RV-size (mm) 0.37±0.10 0.41±0.05 0.37±0.10 0.190
 Thickness (mm) 6±2 5±1 6±2 0.553
Isthmus 3
 Present (n) 49 (100%) 7 (100%) 42 (100%) 1.000
 Width (mm) 10±7 5±2 11±7 0.013
 Width (mm) / RV-size (mm) 0.16±0.08 0.15±0.06 0.16±0.09 1.000
 Thickness (mm) 5±3 3±2 5±3 0.108
Isthmus 4
 Present (n) 3 (6%) 0 (0%) 3 (7%) 0.466
 Width (mm) 4±3 4±3
 Thickness (mm) 2±1 2±1
RV size (mm) 62±19 37±4 67±16 <0.001




to the 42 patients corrected with a transatrial-transpulmonary approach above the age of 1 
year (45±14mm, p=0.009). There was no difference in presence and dimensions of isthmus 
3 between patients corrected with a transatrial-transpulmonary approach below the age of 
1 year and ≥1 year (Table 3). 
Uncorrected specimens: baseline characteristics
The cohort consisted of 58 uncorrected TOF patients (68% male, 33% DORV) with a median 
age of 1.8 (0.5–6.6) years, 6 patients (10%) were >12 years old and the oldest patient was 78 
years. The RV size was 52±19mm. Palliative operations and mode of death are described in 
table 4. Isthmus 3 was present in 55 patients (95%), 10±6mm broad and 5±3mm thick. 
Uncorrected versus corrected specimens
The 58 patients with uncorrected TOF were significantly younger as compared to the 84 
patients with corrected TOF (1.8 (0.5–6.6) years versus 6.6 (4.0–11.5) years, p<0.001). There 
was no statistical significant difference between uncorrected and corrected specimens in 
Table 4. Uncorrected patients: Baseline characteristics.
  All (n=58)
Age (y) 1.8 (0.5-6.6)
Age category (y)
 <1 23 (40%)
 1 - <4 17 (29%)
 4 - <8 5 (9%)
 8 - <12 7 (12%)
 12 - <18 2 (3%)
 18 or older 4 (7%)




 Age 2.0 (0.6-6.2)
 Year 63 (‘57-‘69)
 Type
  Brock 9 (24%)
  Swan 2 (5%)
  Shunt - Potts 4 (11%)
  Shunt - Waterston 9 (24%)
  Shunt - Blalock Tausig 13 (34%)
Death 
 Death perioperative 37/54* (69%)
 Death non-perioperative 17/54* (31%)
DORV, double outlet RV; mm, millimeter; RV, right ventricle; y, year; *, missing data.
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isthmus 3 presence and dimensions. However, this may be partly due to the differences in 
age distribution. For the age subgroups isthmus 3 tended to be wider beyond the age of 1 
in uncorrected specimens, Table 5. Of importance, the range of isthmus 3 width (min - max: 
2 – 32mm) and thickness (min – max: 1 – 13mm) was very large across all ages for both 
corrected and uncorrected patients (Figure 3A-D) and was associated with age (respectively 
r=0.34, p<0.001 and r=0.24, p=0.005). Furthermore, there was a significant correlation 
between isthmus 3 width and thickness (r=0.65, p<0.001). Thus, a narrow isthmus 3 in TOF 
specimens are likely to contain thinner myocardium whereas broader isthmuses consist of 
thicker myocardium in corrected and uncorrected patients (Figure 3E-F). 
DISCUSSION 
To the best or our knowledge, this is the first and largest study of corrected and uncorrected 
post-mortem TOF specimens describing (i) isthmus presence and dimensions related to mode 
and timing of correction and (ii) in uncorrected specimens the age dependent dimensions 
of isthmus 3, i.e. the isthmus located between the PV and VSD-patch which is the result of 
the malformation itself. Based on our extensive collection of post-mortem TOF specimens, 
key findings are (1) that the routinely used transatrial-transpulmonary correction prevented 
the occurrence of isthmus 2 (isthmus between PV and non-transannular RV-incision/patch). 
Transventricular correction was in our collection after July 1975 only used in the presence 
of major coronary aberrancy. Second, mode of correction did not change the presence 
Table 5. Comparison of isthmus 3 between uncorrected and corrected patients.
  Uncorrected (n=58) Corrected (n=84) p
Age (years) 1.8 (0.5-6.6) 6.6 (4.0-11.5) <0.001
Isthmus 3
 Present 55 (95%) 83 (99%) 0.159
 Width (mm): all ages 9 (5-14) 8 (6-13) 0.943
  Width (mm): <1y 5 (3-7) 6 (4-7) 0.649
  Width (mm): 1 - <4y 11 (7-15) 7 (6-8) 0.028
  Width (mm): 4 - <8y 13 (9-16) 8 (6-15) 0.391
  Width (mm): 8 - <12y 15 (9-20) 10 (8-13) 0.038
  Width (mm): 12 - <18y 8 15 (7-19) 0.410
  Width (mm): >18y 23 (11-27) 10 (8-19) 0.330
 Thickness (mm): all ages 4 (2-6) 5 (3-6) 0.721
  Thickness (mm): <1y 2 (2-3) 4 (2-5) 0.279
  Thickness (mm): 1 - <4y 6 (3-7) 4 (3-5) 0.068
  Thickness (mm): 4 - <8y 6 (4-7) 5 (3-6) 0.247
  Thickness (mm): 8 - <12y 8 (6-9) 5 (4-6) 0.020
  Thickness (mm): 12 - <18y 4 6 (3-8) 0.513
  Thickness (mm): >18y 7 (4-11) 6 (3-9) 0.604




and dimensions of isthmus 3. However, isthmus 1 (isthmus between tricuspid annulus and 
RVOT-patch/RV-incision) was thicker after the transatrial-transpulmonary correction. Third, 
a transatrial-transpulmonary correction <1 year as compared to >1 year resulted in the use 
of a smaller transannular patch, which may influence the dimensions of isthmus 1 over time. 
Fourth, the range of isthmus 3 dimensions was large among all ages in both uncorrected 
and corrected TOF specimens, with an association between isthmus width and thickness. 
Figure 3. Scatterplots of isthmus 3 width and age (Panel A-B), scatterplots of isthmus 3 thickness 
and age (Panel C-D) and scatterplots of isthmus 3 thickness and width (Panel E-F). Panel A, C and E: 
uncorrected patients are marked with grey dots and corrected patients with black dots. Panel B, D and 
F: the mean and 95% confidence interval are marked.   
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Influence of mode of repair
In our collection of post-mortem TOF specimens, the transatrial-transpulmonary correction 
prevented the occurrence of isthmus 2 and was routinely used after July 1975, whereas 
the transventricular approach was after July 1975 only used in case of coronary aberrancy 
(only 1 specimen). The prevalence of isthmus 1 and 3 (>both 90%) did not differ between 
both surgical approaches. The high prevalence of isthmus 1 and 3 is in line with recent large 
electroanatomical mapping studies6, 7 and the anatomical study by Moore et al.12 Of interest, 
after the transatrial-transpulmonary approach the myocardium of isthmus 1 remained 
thicker which may influence proarrhythmogenic remodeling over time. Of interest, isthmus 
2, as compared to the other isthmuses, was relatively narrow and thin.12 Electroanatomical 
studies have shown that anatomical isthmuses with slow conduction were significantly 
narrower as compared to anatomical isthmuses with normal conduction.7 A narrow and thin 
isthmus 1 and 2 may be more likely potentially arrhythmogenic. Accordingly, the transatrial-
transpulmonary correction may reduce the risk of substrate formation by preventing isthmus 
2 and by thicker isthmus 1.
Influence of timing in case of a transatrial-transpulmonary correction
In our cohort of specimens with transatrial-transpulmonary correction, there was no 
difference in presence and dimensions (if corrected for total RV length) of isthmus 1 and 
3 between specimens corrected <1 year and ≥1 year. However, the transannular RVOT-
patch, bordering isthmus 1, was 18 mm (95% CI: 6 – 30mm, p=0.009) smaller. Therefore, 
the smaller RVOT-patches in specimens with a transatrial-transpulmonary correction 
<1 year might eventually result in not only a thicker but also a broader isthmus 1 when 
the heart is fully grown as compared to specimens with a transatrial-transpulmonary 
correction ≥1 year. Recent mapping data demonstrated that anatomical isthmuses with 
normal conduction were indeed broader and had more preserved voltages suggesting 
thicker myocardium, as compared to those with slow conduction.7 Therefore, in specimens 
with a transatrial-transpulmonary and with a correction <1 year, isthmus 1 may have less 
often the arrhythmogenic isthmus characteristics (narrow, thin) that are typical for VT 
related isthmuses.
Isthmus 3 is, as compared to isthmus 1, more narrow and thinner12 and therefore 
potentially more often slow conducting and related to VT, which has been confirmed by 
two large mapping studies.6, 7 Despite early repair, isthmus 3 may be arrhythmogenic, as 
demonstrated in a cohort of 15 cTOF patients corrected <2 years in which 5 patients (33%) 
had a slow conducting isthmus which was proven related to VT in 4.7 Therefore, we consider 
isthmus 3 to be the most important potentially arrhythmogenic isthmus in the present 
surgical era in which most patients undergo a transatrial-transpulmonary correction <1 year. 
Isthmus 3: uncorrected versus corrected
In our population of post-mortem TOF specimens the range of isthmus 3 dimensions 




TOF specimens which might be a reflection of the broad anatomical spectrum of 
the malformation. Of importance, there was a strong correlation between width and 
thickness of isthmus 3 in uncorrected and corrected specimen implying that a narrow 
isthmus consists of thinner myocardium. Considering the association between isthmus 
width and slow conduction found in clinical mapping studies we may speculate that in 
particular a narrow isthmus 3, which width is not influenced by the initial repair may show 
pathological remodeling over time providing the substrate for slow conduction and VT. 
It has been shown that the RVOT contains interstitial and replacement fibrosis and 
that the amount of fibrosis is associated with the duration of pressure overload (i.e. age 
of repair).13 Myocyte bundles separated and interspersed by fibrosis provide the substrate 
for reentry VTs. We hypothesize that slow conduction might evolve over time, which may 
be due to adverse remodeling at the border zone between patch material and/or dense 
fibrosis, similar what has been observed at the border zone of myocardial infarction. Adverse 
remodeling may further be promoted by late volume overload in patients with pulmonary 
valve regurgitation. Further studies are required to gain more insight in the substrate for 
slow conduction of isthmus 3 despite early repair. 
Clinical implications 
The current routine use of transatrial-transpulmonary correction <1 year as compared to 
the previous mode and timing of correction prevented isthmus 2, resulted in a thicker 
isthmus 1 and  may result in a broader isthmus 1 in the adult heart, if a smaller transannular 
RVOT-patch has been used. As VT related anatomical isthmuses in the adult TOF are typically 
narrow with low voltages consistent with a thin layer of viable myocardium7, the thicker and 
broader isthmus 1 may less likely serve as a substrate for late VT. Accordingly, the modern 
surgical approach is likely to reduce the risk for VT. In the present surgical era, isthmus 3, 
however, may remain as the only potential proarrhythmogenic isthmus. As demonstrated 
this isthmus is not dependent on the type and timing of surgery but on the variation of 
the malformation. We may therefore consider a preventive intraoperative ablation of 
a ‘narrow and thin’ isthmus 3 during initial repair and, as standard procedure, if re-operation 
needs to be performed. In patients who do not need re-operation, but who are considered 
at risk for VT may undergo invasive VT risk stratification by electroanatomical mapping 
and, if inducible, subsequent ablation.7 Isthmuses 3 that are related to VT as compared 
to isthmuses 3 that are not related to VT tended to be narrower and had lower voltages 
consistent with a thin layer of viable myocardium and subsequently required only short 
ablation lines in prior clinical investigations.7 Therefore, radiofrequency catheter ablation of 
isthmus 3 related VT could be performed with a high acute success rate, and with freedom 
of VT during long-term follow-up.6 Identification of narrow and slow-conducting AI currently 
requires invasive electroanatomical mapping. 7 To overcome the need for invasive VT risk 
stratification in TOF, it would be interesting to further explore if contrast enhanced cardiac 
magnetic resonance imaging (CE-MRI) can reliably delineate anatomical isthmuses. Of 
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importance, there is currently no cutoff value for isthmus size with sufficient discriminative 
power for individualized VT risk stratification.7 In contrast, an isthmus conduction velocity of 
<0.5m/s has been shown to have sufficient discriminative power for individualized VT risk 
stratification. Therefore, additional CE-MRI derived imaging criteria need to be evaluated 
that might be able to identify tissue characteristics consistent with slow conduction. 
Limitations
Most corrected patients died shortly after correction at an age of <18 years. Therefore, 
the study cohort is not fully representative for the population of adult TOF patients (with 
VT). There was too little clinical data on the occurrence of VT to perform analyses between 
isthmus characteristics and VT. Nevertheless, this study comprises the largest cohort of post-
mortem TOF specimens over a long time span ranging from a period of 1936 to 2007, and 
the first to demonstrate a relation between on one hand isthmus presence and dimensions 
and the other hand mode and timing of correction which is relevant for VT risk of present 
and future TOF patients. 
CONCLUSION
The current routine use of transatrial-transpulmonary correction as compared to the only 
incidental use of the ventricular correction prevented the presence of isthmus 2 and was 
associated with thicker isthmus 1. Transatrial-transpulmonary correction <1 year as compared 
to ≥1 year resulted in a smaller transannular patch, which might result in a broader isthmus 
1 when the heart is fully grown. Mode and timing of correction did not change prevalence 
and dimensions of isthmus 3. In uncorrected and corrected post-mortem TOF specimens, 
the range of isthmus 3 dimensions was broad across all ages. The strong association between 
isthmus 3 width and thickness and the clinical association between a narrow isthmus and 
slow conduction facilitating VT may have important implication for the management of 
contemporary TOF patients. A narrow isthmus 3 may remain the only potential substrate for 
late VTs which could be targeted during initial repair or re-operation. 
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What is already known about this subject?
Ventricular tachycardia (VT) is an important cause for late mortality and morbidity in 
corrected tetralogy of Fallot (TOF). The dominant substrate for VT in TOF are anatomical 
isthmuses with slow conduction. There are four anatomical isthmuses which are the result of 
the malformation itself and surgical correction. 
What does this study add?
This study supports the hypothesis that the current routine use of transatrial-transpulmonary 
correction below the age of 1 year prevents isthmus 2 (between pulmonary valve (PV) and 
right ventricular (RV) incision/RV outflow tract (RVOT) patch) and is associated with thicker 
myocardium within isthmus 1 (between tricuspid annulus and RV-incision/RVOT-patch). 
In addition, the reduced transannular-patch size may result in a broader isthmus 1 later 
in life. Mode and timing of repair did not influence dimensions of isthmus 3 (between PV 
and ventricular septal defect patch) which varied widely across all ages. The demonstrated 
association between isthmus 3 width and thickness of the myocardium and the earlier 
demonstrated clinical association between narrow isthmus 3 and VT strongly suggest that 
a narrow isthmus 3 is likely to undergo pro-arrhythmogenic remodeling over time.
How might this impact on clinical practice?
In TOF, isthmus 3, especially a narrow isthmus 3, may be the last remaining potentially 
arrhythmogenic isthmus and may be a target for preventive ablation during initial repair 
or re-operation.
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Palliative operation before correction 39 (46%) 18 (51%) 21 (43%) 0.437
 Age (y) 3.0 (1.4-4.9) 2.9 (1.6-5.0) 3.5 (0.6-4.9) 0.988
 Interval first PO - correction (y) 4.2 (2.2-8.5) 4.6 (2.9-9.9) 4.0 (2.0-6.0) 0.313
 Type
  Brock 1 (3%) 1 (6%) 0 (0%) 0.102
  Shunt - Potts 11 (28%) 8 (44%) 3 (14%)
  Shunt - Waterston 4 (10%) 1 (6%) 3 (14%)
  Shunt - Blalock Taussig 23 (59%) 8 (44%) 15 (71%)  
PO, palliative operation; y, year.
A2. TOF patient with LAD from RCA crossing over right ventricular outflow tract, subsequently corrected 
with transventricular approach. TOF patient corrected with transventricular approach after July 1975. 
Isthmus 2 (marked with brackets) located between two right ventricular outflow tract (RVOT) patches 
due to an aberrant left anterior descending artery (LAD). The aberrant LAD (marked with •) originates 
from the right coronary artery. Isthmus 1 is also present, located between the non-transannular 




Summary, Conclusions and Future Perspectives





This thesis describes the anatomical features, repair and epidemiology of tetralogy of 
Fallot (TOF) and the challenges of non-invasive risk stratification and invasive treatment 
of ventricular tachycardia in TOF. TOF is classically characterized by a (sub)pulmonary 
stenosis, ventricular septal defect (VSD), overriding of the aortic orifice and secondary 
concentric right ventricular (RV) hypertrophy. During repair, the VSD is closed with 
a patch and the (sub)pulmonary stenosis is relieved. In the past, repair was performed via 
a transventricular approach in the first decade of life. Nowadays, repair is performed via 
a transatrial-transpulmonary approach in the first year of life. Due to the good surgical 
outcome, the prevalence of adults with TOF has doubled between 1980 and 2010 from 0.1 
to 0.2 per 1000 adults and is expected to increase even further. Adults with TOF still have 
a 29 fold higher risk to die suddenly as compared to healthy matched controls. The burden of 
ventricular arrhythmias in TOF is considerable with a prevalence of 15%, observed in a cohort 
of 556 adult TOF patients with a mean age of 37±12 years. Eighty percent of these ventricular 
arrhythmias are fast monomorphic macro-reentrant ventricular tachycardia (average of 213 
beats per minute) and related to anatomical isthmuses. The anatomical isthmuses in TOF are 
the result of the malformation itself or the surgical repair and are bordered by valve annuli, 
patch-material and/or incisions. The value of non-invasive risk factors is limited. A limited 
number of case series and very small cohorts studies reported that radiofrequency catheter 
ablation of VT in adults with TOF is a feasible option, especially substrate mapping permits 
ablation of fast and hemodynamically unstable VTs. 
In chapter two, in a cohort of 74 repaired TOF patients who were considered at risk for 
VT, the properties of the anatomical isthmuses (i.e. width, length and conduction velocity) 
were determined by electroanatomical mapping during sinus rhythm. All patients had 
a least one anatomical isthmus and 28 patients were inducible for 41 VTs. The anatomical 
isthmuses of the 28 patients with inducible VT as compared to anatomical isthmuses of 
the 46 patients without inducible VT were narrower and longer and demonstrated a lower 
conduction velocity index (CVi). Thirty-seven of the 41 inducible VTs were mapped to an 
anatomical isthmus. All anatomical isthmuses related to VT had a conduction velocity of 
<0.5m/s (defined as slow conducting anatomical isthmus). In contrast, 87 of 89 anatomical 
isthmuses in 46 patients without inducible VT had a CVi of ≥0.5m/s. All 62 patients without 
a slow conducting anatomical isthmus, 44 at baseline and 18 after ablation, were free from 
VT during a follow-up of 262 patient years (average 5±2 years). The reported ventricular 
arrhythmia event rates in patients with comparable risks factors who received an ICD for 
primary of secondary prevention were 8-10% per year, which was also observed in our 
cohort of patients discharged with a slow conducting anatomical isthmus. These findings 
confirm the strong link between slow conducting anatomical isthmuses and VT in TOF. 
Chapter three describes the acute and long-term outcome of radiofrequency catheter 
ablation (RFCA) of anatomical isthmus related VT with the use of substrate mapping in a large 




TOF. These 34 patients were inducible for a median of 1 (inter quartile range: 1 – 2) VT and 
VTs were fast with a median cycle length of 295ms (inter quartile range: 242 – 346). Acute 
success, defined as bidirectional block of the anatomical isthmus that contained the critical 
VT re-entry site and non-inducibility of any VT after ablation, was achieved in 25 patients 
(74%). All 25 patients with acute success remained free from VT during follow-up (4±2years), 
only 1 patient with a depressed cardiac function and an ICD experienced an episode of 
ventricular fibrillation. In contrast, 4 of the 9 patients without acute success experienced VT 
during long-term follow-up. 
In the cohort, described in Chapter 3, of the 28 consecutive TOF patients that underwent 
radiofrequency catheter ablation of anatomical isthmus related VT, VT ablation failed in 11 
patients after a right-sided procedure. VT was mapped in 8 of these 11 patients to a septal 
anatomical isthmus. A left-sided approach was not performed in 4 patients due to procedural 
reasons such as procedure length, patient condition and/or pathology of the aortic valve. 
The 4 patients that did undergo a left-sided approach are reported in chapter four. In 3 
patients with a left-sided approach, radiofrequency catheter ablation in the aortic root 
resulted in acute success. In 1 patient with prior biventricular cardioverter-defibrillator 
implantation diastolic activity during VT was recorded at the His-bundle and ablation 
resulted in acute success and as anticipated in AV-block. The right-sided failure in these 
four patients was probably due to hypertrophy of the myocardium, an overlying pulmonary 
homograft and VSD-patch. All four patients remained free from VT during a follow-up of 
2±1 years.
The fifth chapter describes the contribution of the VT substrate to QRS duration according 
to absence or presence of right bundle branch block (RBBB) in a cohort 78 TOF patients 
that underwent VT induction and electroanatomical mapping during sinus rhythm. Twenty-
four patients were inducible for VT, 22 of the 24 patients with VT had a slow conducting 
anatomical isthmus. In contrast, only 2 of the 54 patients without VT had a slow conducting 
anatomical isthmus. As expected the conduction velocity through the anatomical isthmuses 
was lower in patients with VT. There was no difference in remote RV conduction velocity and 
RV size between patients with and without VT. In the 11 patients with a narrow QRS, the QRS 
duration was similar for patients with and without VT. However, total RV activation time and 
RV activation after QRS-offset were significantly longer in narrow QRS patients with VT. The RV 
activation after QRS-offset was confined to the slow conducting anatomical isthmuses not 
contributing to the 12 lead ECG. In the 67 RBBB patients, both total RV activation time and 
QRS duration were longer in patients with inducible VT. RBBB patients with QRS duration 
≥150ms as compared to RBBB patients with QRS duration <150ms were 14 times more like 
to be inducible for VT. 
The final chapter (Chapter 6) reports on the influence of repair itself, mode of repair and 
timing of repair on anatomical isthmus presence and dimensions in a cohort of 142 TOF post-
mortem specimens (84 corrected and 58 uncorrected). Anatomical isthmus 1, the isthmus 
between the tricuspid annulus and RVOT-patch/RV-incision, and isthmus 3, isthmus between 
the pulmonary annulus and VSD, were the most prevalent anatomical isthmuses and present 
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in 99% of the specimens. The currently used transatrial-transpulmonary repair as compared 
to transventricular repair prevented isthmus 2, the isthmus between pulmonary annulus 
and RVOT-patch/RV-incision, and was associated with a thicker isthmus 1. Transatrial-
transpulmonary correction <1 year as compared to ≥1 year resulted in a smaller transannular 
patch, which might result in a broader isthmus 1 when the heart is fully grown. Mode and 
timing of correction did not change prevalence and dimensions of isthmus 3. In uncorrected 
and corrected post-mortem TOF specimens, the range of isthmus 3 dimensions was 
broad across all ages. The strong association between isthmus 3 width and thickness and 
the clinical association between a narrow isthmus and slow conduction facilitating VT may 
have important implication for the management of contemporary TOF patients. A narrow 
isthmus 3 may remain the only potential substrate for late VTs in the present surgical era.
CONCLUSIONS
The prevalence of adults with TOF is 0.2 per 1000 adults and is expected to further increase 
due to the good surgical outcome. Nevertheless, adults with TOF still have a 29 fold higher 
risk to die suddenly as compared to healthy matched controls. The burden of ventricular 
arrhythmias in TOF is considerable with a prevalence of 15% and are an important cause for 
late morbidity and mortality. The majority of the ventricular arrhythmias are monomorphic 
VT. The dominant substrate for VT in TOF are slow conducting anatomical isthmuses which 
can be identified by electroanatomical mapping during sinus rhythm allowing individualized 
risk stratification and preventive ablation. Radiofrequency catheter ablation of anatomical 
isthmus related VT in repaired congenital heart disease, especially in TOF, can be performed 
with a high acute success rate. In case of right-sided failure of radiofrequency catheter 
ablation of septal anatomical isthmus related VT in TOF, left-sided ablation can be performed 
successfully and safely. Provided that bidirectional block of the anatomical isthmus that 
contains the critical VT re-entry site is achieved, radiofrequency catheter ablation of 
anatomical isthmus related VT in TOF can be even considered curative and prevent ICD 
implantation in presence of a preserved cardiac function. Slow conducting anatomical 
isthmuses are an important link between QRS duration and risk of VT in TOF patients. In 
TOF patients with pre-existing right bundle branch block, the slow conducting anatomical 
isthmuses prolong right ventricular activation time and QRS duration. A narrow QRS in TOF 
does not exclude VT and presence of a slow conducting anatomical isthmus. In TOF, the most 
prevalent arrhythmogenic anatomical isthmus is the isthmus between the pulmonary valve 
and ventricular septal defect, i.e. isthmus 3. Isthmus 3 is not influenced by repair itself, nor 
by mode or timing of repair. Therefore isthmus 3 is expected to remain the most important 
arrhythmogenic isthmus in future TOF patients. 
FUTURE PERSPECTIVES
The dominant substrate for VT in TOF are slow conducting anatomical isthmuses which can 




risk stratification and preventive ablation, which can be curative and can in presence of 
a preserved biventricular function prevent ICD implantation. Currently we do not know 
the best moment for invasive risk stratification and we do not know if one procedure is 
sufficient. Further studies focusing on the mechanism of slow conduction within these 
anatomical isthmuses of TOF patients is required in order to optimally time invasive VT risk 













In dit proefschrift worden de anatomische kenmerken, correctie en epidemiologie van 
tetralogie van Fallot (TOF) en de uitdagingen van niet-invasieve risico stratificatie en 
invasieve behandeling van ventrikel tachycardie (VT) in TOF beschreven. Klassieke TOF wordt 
gekenmerkt door een (sub)pulmonale stenose, ventrikel septum defect (VSD), overrijdende 
aorta en hieraan secundaire concentrische rechter ventrikel (RV) hypertrofie. De chirurgische 
correctie bestaat uit het sluiten van het VSD met een patch en het opheffen van de (sub)
pulmonale stenose. In het verleden werd de correctie verricht middels een transventriculaire 
benadering binnen de eerste 10 jaar van het leven. De transventriculaire benadering houdt 
in dat de chirurgische correctie wordt uitgevoerd via een incisie in de RV. Tegenwoordig 
wordt de correctie verricht via een transatriale-transpulmonale benadering in het eerste 
levensjaar. De transatriale-transpulmonale benadering houdt in dat de chirurgische correctie 
wordt uitgevoerd via een incisie in het rechter atrium en de arteria pulmonalis. De goede 
chirurgische technieken hebben geresulteerd in een verbetering van de overleving, met 
verdubbeling van de prevalentie van volwassenen met TOF tussen 1980 en 2010, namelijk 
van 0.1 naar 0.2 per 1000 volwassenen. Er wordt verwacht dat de prevalentie van volwassen 
met TOF nog zelfs verder zal toenemen. Volwassenen met TOF hebben een 29 maal zo hoog 
risico om plots te overlijden ten op zichten van gezonde leeftijdsgenoten. De prevalentie 
van ventriculaire ritmestoornissen in TOF is met 15% behoorlijk hoog. Deze hoge prevalentie 
werd geobserveerd in een cohort van 556 volwassen TOF patiënten met een gemiddelde 
leeftijd van 37±12 jaar. Tachtig procent van deze ventriculaire ritmestoornissen zijn snelle 
monomorfe macro reentry ventrikel tachycardieën met een gemiddelde snelheid van 213 
slagen per minuut en gerelateerd aan anatomische isthmuses. Een anatomische isthmus is 
een smal stukje hartspierweefsel dat aan beide kanten wordt begrensd door anatomische 
structuren. De anatomische isthmuses in TOF zijn inherent aan het congenitale defect of het 
gevolg van de chirurgische correctie en worden begrensd door klepringen, patch materiaal 
en/of RV incisies. Het voorspellend vermogen van niet-invasieve risicofactoren voor VT is 
beperkt. Een beperkt aantal cases en zeer kleine cohort studies hebben aangetoond dat 
radiofrequente katheter ablatie van VT in volwassenen met TOF een aantrekkelijk optie is, 
waarbij substraat mapping het mogelijk maakt om snelle en hemodynamische instabiele 
VT te ableren. Ableren houdt in dat een klein stukje hartspierweefsel wordt opgewarmd 
of wordt bevroren waardoor littekenweefsel ontstaat. Het geableerde hartspierweefsel 
kan vervolgens geen elektriciteit meer geleiden. In het geval van het ableren van een 
VT wordt het kritieke onderdeel van het VT circuit geableerd waardoor het VT circuit 
wordt onderbroken.
In hoofdstuk twee werden de eigenschappen van de anatomische isthmus (breedte, 
lengte en geleidingssnelheid) gemeten in 74 gecorrigeerde TOF patiënten, die risico lopen 
op VT, met het gebruik van elektro anatomische mapping tijdens sinus ritme. Elektro 
anatomische mapping houdt in dat de elektrische activatie op meerdere plekken in het 




anatomische map geeft vervolgens een duidelijk overzicht van de elektrische activatie van 
het hart. Alle TOF patiënten hadden tenminste 1 anatomische isthmus en 28 patiënten 
waren induceerbaar voor 41 VT. De anatomische isthmus van de 28 patiënten met VT ten 
op zichten van de 46 patiënten zonder VT waren smaller, langer en hadden een lagere 
geleidingssnelheid. Zevenendertig van de 41 VT waren gerelateerd aan een anatomische 
isthmus. Alle VT gerelateerde anatomische isthmuses hadden een geleidingssnelheid van 
<0.5 m/s (gedefinieerd als een traag geleidende anatomische isthmus). Daarentegen, 87 van 
89 anatomische isthmuses van de 46 patiënten zonder VT hadden een geleidingssnelheid 
van ≥0.5ms. Alle 62 patiënten zonder traag geleide anatomische isthmus, 44 patiënten bij de 
eerste beoordeling en 18 patiënten na ablatie, hadden geen VT tijdens een periode van 262 
patiëntjaren (gemiddeld 5±2 jaar per patiënt). Eerdere studies in patiënten met vergelijkbare 
risicofactoren en een ICD (primaire en secundaire preventie) hebben een VT prevalentie van 
8-10% per jaar aangetoond. Deze prevalentie was gelijk in ons cohort van TOF patiënten die 
ontslagen werden met een traag geleidende anatomische isthmus. Dit bevestigt de sterke 
associatie tussen traag geleidende anatomische isthmus en VT in TOF. 
Hoofdstuk 3 beschrijft de directe en lange termijn uitkomst van radiofrequente katheter 
ablatie van anatomisch isthmus gerelateerde VT met behulp van substraat mapping in 
een grote groep van 34 patiënten met een gecorrigeerde aangeboren hart afwijking. 
Achtentwintig van de 34 patiënten hadden TOF. Deze 34 patiënten waren induceerbaar voor 
snelle VT met een mediane cyclus lengte van 295ms (inter kwartiel: 242 – 346). Acuut succes, 
gedefinieerd als bidirectionele blokkade van de anatomische isthmus die gerelateerd was 
aan de VT en niet-induceerbaarheid van VT na ablatie, werd behaald in 25 patiënten (74%). 
Alle 25 patiënten met acuut succes hadden geen VT tijdens follow-up (4±2 jaar), slechts 1 
patiënt met hartfalen kreeg een ICD schok voor ventrikel fibrilleren. Daarentegen hadden 4 
van 9 patiënten zonder acuut succes een VT recidief. 
In het cohort van de 28 TOF patiënten, die radiofrequente katheter ablatie van 
anatomische isthmus gerelateerde VT ondergingen (Hoofdstuk 3), was VT ablatie in 
11 patiënten niet succesvol na een rechtszijdige benadering. De VT was in 8 van de 11 
patiënten gerelateerd aan een septale anatomische isthmus. Een septale anatomische 
isthmus is gelegen tussen beide ventrikels. Een linkszijdige benadering werd niet verricht 
in 4 patiënten vanwege procedure tijd, conditie van de patiënt en/of aortaklep pathologie. 
De overige 4 patiënten die wel een linkszijdige procedure ondergingen werden beschreven 
in hoofdstuk 4. Radiofrequente katheter ablatie in de aortawortel termineerde VT en 
resulteerde in acuut succes in 3 patiënten. In 1 patiënt met reeds een biventriculaire ICD 
werd diastolische activiteit gezien ter plaatse van de His-bundel waar ablatie resulteerde in 
acuut succes en zoals verwacht in totaal AV-blok. Rechtszijdige ablatie lukte in deze patiënten 
waarschijnlijk niet vanwege hypertrofie van het myocard, een overliggende pulmonalis 
homograft of VSD-patch. Alle vier patiënten met een linkszijdige procedure hadden geen VT 
tijdens follow-up (2±1 jaar). 
Het vijfde hoofdstuk beschrijft de bijdrage van het VT substraat aan QRS duur in 
de afwezigheid en aanwezigheid van een rechter bundeltak blok (RBTB) in een cohort 
Samenvatting, Conclusies en Toekomstperspectief
143
8
van 78 TOF patiënten die VT inductie en elektro anatomische mapping tijdens sinus 
ritme ondergingen. Vierentwintig patiënten waren induceerbaar voor VT, 22 van de 24 
patiënten met VT hadden een traag geleidende anatomische isthmus. Een traag geleidende 
anatomische isthmus werd in slechts 2 van de 54 patiënten zonder VT geobserveerd. 
De geleidingssnelheid van de anatomische isthmus van patiënten met VT was, zoals 
verwacht, lager. Er was geen verschil in RV geleidingssnelheid en RV grootte tussen patiënten 
met en zonder VT. In de 11 patiënten met een smal QRS complex was er geen verschil in 
QRS duur tussen patiënten met en zonder VT. Echter, de totale RV activatie tijd en de RV 
activatie na het einde van het QRS complex waren beide langer in patiënten met een smal 
QRS complex en VT. De RV activatie na het einde van het QRS complex was gelokaliseerd ter 
plaatse van de traag geleidende anatomische isthmus, derhalve droeg deze niet bij aan het 
oppervlakte ECG. In de 67 patiënten met RBTB waren zowel de totale RV activatie tijd als de 
QRS duur langer in RBTB patiënten met VT ten opzichte van RBTB patiënten zonder VT. RBTB 
patiënten met een QRS duur ≥150ms ten opzichte van <150ms hadden een 14 maal zo hoge 
kans op induceerbare VT. 
Het laatste hoofdstuk (Hoofdstuk 6) beschrijft de invloed van de correctie zelf, methode 
van de correctie en moment van de correctie op de aanwezigheid en eigenschappen 
van de anatomische isthmus in een cohort van 142 post mortem TOF harten (84 gecorrigeerd, 
58 ongecorrigeerd). Anatomische isthmus 1, de isthmus tussen de tricuspidalis annulus en 
een RVOT patch/RV incisie, en anatomische isthmus 3, de isthmus tussen de pulmonalis 
annulus en het VSD, waren de meest prevalente anatomische isthmus en aanwezig in 99% van 
de post mortem TOF harten. De huidige transatriale-transpulmonale methode ten opzichte 
van de transventriculaire methode zorgde ervoor dat anatomische isthmus 2, de isthmus 
tussen de pulmonalis annulus en een RVOT patch/RV incisie, niet meer aanwezig was en was 
geassocieerd met een dikkere isthmus 1. De transatriale-transpulmonale methode onder 
de leeftijd van 1 jaar ten opzichte van ≥1 jaar resulteerde in het gebruik van een kleinere 
RVOT-patch, die uiteindelijk zou kunnen resulteren in een bredere isthmus 1 op het moment 
dat het hart volgroeid is. De methode en het moment van correctie hadden geen invloed 
op de aanwezigheid en dimensies van isthmus 3. De spreiding van isthmus 3 dimensies 
(dikte en breedte) was groot op alle leeftijden in zowel gecorrigeerde als ongecorrigeerde 
post mortem TOF harten. De sterke associatie tussen de breedte en dikte van isthmus 3 en 
de bekende klinische associatie tussen een smalle anatomische isthmus en trage geleiding 
welke VT faciliteren, hebben belangrijke implicaties voor behandeling van huidige TOF 
patiënten. Een smalle isthmus 3 is mogelijk nog het enige substraat voor VT in TOF in het 
huidige chirurgische tijdsvlak. 
CONCLUSIES
De prevalentie van volwassenen met TOF is 0.2 per 1000 volwassenen en zal verder 
toenemen vanwege de goede chirurgische resultaten. Volwassenen met TOF hebben 




gezonde leeftijdsgenoten. De prevalentie van ventriculaire ritmestoornissen in volwassen 
TOF patiënten is hoog met 15%. Ventriculaire ritmestoornissen in TOF zijn een belangrijke 
oorzaak voor morbiditeit en mortaliteit bij volwassenen. Het merendeel van deze 
ventriculaire ritmestoornissen zijn monomorfe VTs. Het dominante substraat voor VT in 
TOF zijn traag geleidende anatomische isthmuses die geïdentificeerd kunnen worden met 
elektro anatomische mapping tijdens sinus ritme waardoor individuele risicostratificatie en 
preventieve ablatie mogelijk is. Radiofrequente katheter ablatie van anatomisch isthmus 
gerelateerde VT in corrigeerde aangeboren hartafwijkingen kan worden uitgevoerd met een 
hoog acuut succes, met name in TOF. In het geval dat rechtszijdige radiofrequente katheter 
ablatie van een septale anatomisch isthmus gerelateerde VT in TOF niet succesvol is, kan 
linkszijdige ablatie veilig en succesvol worden verricht. Op het moment dat bidirectioneel 
blok bereikt kan worden van de anatomische isthmus die de kritieke isthmus van de 
VT bevat, kan radiofrequente katheter ablatie van anatomisch isthmus gerelateerde VT 
als curatief worden beschouwd en kan zelfs in patiënten met een behouden hartfunctie 
een ICD implantatie voorkomen. De traag geleidende anatomische isthmuses zijn een 
belangrijke link tussen de QRS duur en het risico op VT in TOF patiënten. De traag geleidende 
anatomische isthmus in TOF patiënten met RBTB verlengen namelijk de totale RV activatie 
tijd en QRS duur. Een smal QRS complex in TOF sluit echter VT en de aanwezigheid van een 
traag geleidende anatomische isthmus niet uit. De meest prevalente aritmogene isthmus 
in TOF is de isthmus tussen de pulmonalis annulus en het VSD, namelijk isthmus 3. Isthmus 
3 wordt niet beïnvloed door de correctie zelf, niet door methode van correctie en niet 
door het moment van correctie. Het is daarom de verwachting dat anatomische isthmus 3 
de meest aritmogene anatomische isthmus zal blijven in toekomstige TOF patiënten. 
TOEKOMSTPERSPECTIEF
Het dominante substraat voor VT in TOF zijn traag geleidende anatomische isthmuses die 
geïdentificeerd kunnen worden met elektro anatomische mapping tijdens sinus ritme 
waardoor individuele risicostratificatie en preventieve ablatie mogelijk is. Een succesvolle 
radiofrequente katheter ablatie van anatomisch isthmus gerelateerde VT in TOF kan 
als curatief worden beschouwd en kan bij behouden hartfunctie zelfs ICD implantatie 
voorkomen. Op dit moment is het onbekend wat het beste moment is voor invasieve 
risicostratificatie en het is onbekend of één procedure voldoende is. Toekomstige studies 
zouden daarom gericht moeten worden op het ophelderen van het mechanisme achter het 
ontstaan van trage geleiding van de anatomische isthmus in TOF om op die manier het beste 
moment vast te stellen voor invasieve risicostratificatie en/of preventieve ablatie mogelijk 
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